Lung Paraquat Content and Effects on the Lung Glutathione Antioxidant System, Nadph, and Polyamines Resulting From Intravenous Coinfusion of Paraquat and Putrescine to Rats by Dunbar, Jacob R.
East Tennessee State University
Digital Commons @ East
Tennessee State University
Electronic Theses and Dissertations Student Works
May 1987
Lung Paraquat Content and Effects on the Lung
Glutathione Antioxidant System, Nadph, and
Polyamines Resulting From Intravenous
Coinfusion of Paraquat and Putrescine to Rats
Jacob R. Dunbar
East Tennessee State University
Follow this and additional works at: https://dc.etsu.edu/etd
Part of the Pharmacology Commons
This Dissertation - Open Access is brought to you for free and open access by the Student Works at Digital Commons @ East Tennessee State
University. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of Digital Commons @ East
Tennessee State University. For more information, please contact digilib@etsu.edu.
Recommended Citation
Dunbar, Jacob R., "Lung Paraquat Content and Effects on the Lung Glutathione Antioxidant System, Nadph, and Polyamines
Resulting From Intravenous Coinfusion of Paraquat and Putrescine to Rats" (1987). Electronic Theses and Dissertations. Paper 2669.
https://dc.etsu.edu/etd/2669
INFORMATION TO USERS
While the most advanced technology has been used to 
photograph and reproduce this manuscript, the qualify of 
the reproduction is heavily dependent upon the qualify of 
the material submitted. For example:
•  Manuscript pages may have indistinct print. In such 
cases, the best available copy has been filmed.
•  Manuscripts may not always be complete. In such 
cases, a note will indicate that it is not possible to 
obtain missing pages.
•  Copyrighted material may have been removed from 
the manuscript. In such cases, a note will indicate the 
deletion.
Oversize materials (e.g., maps, drawings, and charts) are 
photographed by sectioning the original, beginning at the 
upper left-hand corner and continuing from left to right in 
equal sections with small overlaps. Each oversize page is 
also filmed as one exposure and is available, for an 
additional charge, as a standard 35mm slide or as a 17”x 23” 
black and white photographic print.
Most photographs reproduce acceptably on positive 
microfilm or microfiche but lack the clarity on xerographic 
copies made from the microfilm. For an additional charge, 
35mm slides of 6”x 9” black and white photographic prints 
are available for any photographs or illustrations that 
cannot be reproduced satisfactorily by xerography.
8715785
D un b ar, J a c o b  R o ss , III
LUNG PARAQUAT CONTENT AND EFFECTS ON THE LUNG GLUTATHIONE 
ANTIOXIDANT SYSTEM, NADPH, AND POLYAMINES RESULTING FROM 
INTRAVENOUS COINFUSION OF PARAQUAT AND PUTRESCINE TO RATS
Easf Tennessee Sfafe University PH.D, 1987
University
Microfilms
International 300 N. Zeeb Road, Ann Aibor, Ml 48106
PLEASE NOTE:
In all cases this material has been filmed In the best possible way from the available copy. 
Problems encountered with this docum ent have been Identified herewith a  check mark V .
S
1. Glossy photographs or p ag es______
2. Colored illustrations, paper o r print ^
3. Photographs with dark background ^
A, Illustrations are poor copy_______
5. Pages with black marks, not original copy
6. Print shows through as  there Is text on both sides of p a g e _______
7. Indistinct, broken o r small print on several pages /
8. Print exceeds m argin requirem ents______
9. Tightly bound copy with print lost In sp ine_______
10. Computer printout pages with indistinct print_______
11. Page{s)____________ lacking when material received, a n d  not available from school or
author.
12. Page(s)____________ seem to be  missing In numbering only as text follows.
13. Two pages num bered  . Text follows.
14. Curling and wrinkled p a g es______
15. Dissertation contains pages with print at a  slant, filmed a s  received__________
16. Other__________________________________________________________________________
University
Microfilms
International
LUNG PARAQUAT CONTENT AND EFFECTS ON THE LUNG GLUTATHIONE ANTIOXIDANT 
SYSTEM, NADPH, AND POLYAMINES RESULTING FROM INTRAVENOUS 
COINFUSION OF PARAQUAT AND PUTRESCINE TO RATS
A Dissertation 
Presented to 
the Faculty of the Department of Pharmacology 
Quillen-Dishner College of Medicine 
East Tennessee State University
In Partial Fulfillment 
of the Requirements for the Degree 
Doctor of Philosophy
by
Jacob R. Dunbar III 
May, 1987
APPROVAL
This is to certify that the Graduate Committee of
JACOB R. DUNBAR III
met on the
day of w £ z .
The committee read and examined hia dissertation, supervised his 
defense of it in an oral examination, and decided to recommend that his 
study be submitted to the Graduate Council and the Associate 
Vice-President for Research and Graduate Studies in partial fulfillment 
of the requirements for the degree of Doctor of Philosophy in Biomedical 
Science.
CommitteeChat
Signed on behalf of . C * 4 p >
the Graduate Council Associate Vice-President for Ttesearch
and Dean of the Graduate School
ii
ABSTRACT
LUNG PARAQUAT CONTENT AND EFFECTS ON THE LUNG GLUTATHIONE ANTIOXIDANT 
SYSTEM, NADPH, AND FOLYAMINES RESULTING FROM INTRAVENOUS 
COINFUSION OF PARAQUAT AND PUTRESCINE TO RATS
by
Jacob R. Dunbar III
Paraquat was administered to male, Sprague-Dawley rats via 
continoua infusion, at dosage rates of 250 (LoPQ) or 500 (HiPQ) 
nmoles/hr for seven days. The purpose was to characterise the effects of 
prolonged, low blood levels of the herbicide on selected lung 
biochemical parameters. The efficacy of putrescine as an inhibitor of 
pulmonary paraquat accumulation, in vivo, was assessed in these animals 
by I.V. coinfusion of 2500 or 5000 nmoles putrescine/hr. Dose-dependent 
levels of both paraquat and putrescine were achieved by 18 hours and 
were maintained throughout the exposure period. Terminal lung paraquat 
content was also dose-dependent and up to 18-fold greater than 
corresponding blood levels, indicative of pulmonary accumulation of the 
herbicide. Despite relatively high putrescine dosage rates, resulting 
blood levels of this diamine were low and did not significantly alter 
terminal lung paraquat content. No evidence of paraquat toxicity was 
seen in LoPQ animals while frank toxicity was observed in the HiPQ 
animals beginning between the fourth and fifth day. Qualitative 
histopathological examination of the lungs revealed changes typical of 
paraquat toxicity (e.g., interstitial edema, increase in type II cells) 
resulting from HiPQ. Significant increases were found in levels of lung 
glutathione and activities of the GSH peroxidase system enzymes, 
glucose-6-phosphate dehydrogenase and GSSG reductase. These changes were 
probably the result of paraquat-induced oxidant stress and increased 
NADPH requirements. Elevations in lung putrescine, spermidine, and 
ornithine decarboxylase activity were detected in HiPQ animals only, and 
reflected the observed lung damage and/or resulting "proliferative" 
state of the tissue rather than a direct response to paraquat. As in the 
case of pulmonary oxygen toxicity, the increased levels of lung 
polyamines may serve to mediate a reparative response to 
paraquat-induced lung damage. The results demonstrate only a narrow 
difference between a paraquat dose which produces no apparent lung 
damage but stimulates components of the GSH peroxidase antioxidant 
system and one which causes characteristic, paraquat-induced lung 
damage. The experimental model employed here represents a useful means 
to study subtle, paraquat-induced biochemical and morphological 
alterations in lung by avoiding paraquat doses which rapidly produce 
lung damage or are directly toxic to extrapulmonary tissues.
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CHAPTER 1 
Introduction
Literature Review 
Summary of biochemical mechanisms of paraquat toxicity
Paraquat (1, 1'-dimethy1-4, 4 ’-bipyridilium dichloride) Is a 
quaternary blpyrldyl compound commonly used as a broad spectrum 
herbicide. It is notorious for its lung-specific toxicity which leads 
to dramatic and Inexorable deterioration of lung function with fatality 
resulting from respiratory failure. The pulmonary toxicity of paraquat 
is described as occurring In two phases (Heath and Smith, 1977). The 
first is a "destructive phase," characterized by damage to alveolar 
epithelial cells and pulmonary edema. Animals that survive this initial 
phase progress to the "proliferative" phase which begins three to four 
days after a single toxic dose. During this time, profibroblasts begin 
to migrate to the alveoli where they differentiate into fibroblasts, 
with resultant development of lntraalveolar fibrosis.
The cyclic, reductlon-oxldatlon of this compound (Figure 1) Is 
widely held to be the initiator of biochemical events leading to the 
inevitable destruction of lung function. This redox cycling of paraquat 
Involves its enzymatic, one-electron reduction via NADPH-cytochrome 
c reductase to a free-radical. The paraquat free-radical is rapidly 
reoxldized by molecular oxygen to the parent molecule with concomitant 
production of a superoxide anion free-radical (Gage, 1968; Farrington et 
al., 1973; Ilet et al., 1974; Bus et al., 1974 and 1975). While no net 
metabolism of paraquat occurs, there are two important consequences of 
these reactions which are thought to contribute to the biochemical
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Figure 1. Reduction-Oxidation Cycling of Paraquat and Possible Consequences
mechanisms of pulmonary toxicity (Bus and Gibson, 1984):
1. production of superoxide radicals and other "activated oxygen" 
species which may cause oxidant damage to structural and 
functional macromolecules of the cell
2. depletion of NADPH which Is required for biosynthetic pathways 
such as fatty acid production and for antioxidant mechanisms 
—  specifically, the glutathione peroxidase/glutathione 
reductase system (Figure 1)
All tissues should be susceptible to this type of toxicity.
Indeed, kidney, gastrointestinal, and liver dysfunction can result from 
paraquat intoxication (Gibson and Cagen, 1977). However, In animals 
surviving the Initial Insult, the "target organ" of paraquat toxicity is 
the lung. The two most widely supported explanations for this 
lung-specific toxicity are
1. the continuous exposure of the lungs to high oxygen tensions 
relative to other tissues may result In a -more rapid redox 
cycling of paraquat in the lung with concomitantly higher 
rates of superoxide production and NADPH oxidation (Fisher et 
al., 1973; Bus et al., 1977; Bus and Gibson, 1984)
2. the ability of the lung to accumulate paraquat to a level much 
higher than that of blood (Ilet et al,, 1974; Rose and Smith, 
1977a and 1977b; Sharp et al., 1972; Litchfield et al., 1973; 
VTltschl et al., 1977; Molnar and Hayes, 1971)
The Importance of pulmonary accumulation of paraquat to the 
specificity of paraquat toxicity is Illustrated through contrasts In 
toxicity of paraquat with that of the the related bipyridilium compound,
dlquat (Sharp et alM  1972; Litchfield et al., 1973; Rose and Smith,
1977 and 1977b; Hitachi et al., 1977; Rose et al., 1974). The acute 
LD^g'a of these compounds are nearly equal (21 mg/kg) when administered 
Intravenously to ratB (Sharp et al., 1972), but dlquat does not produce 
the lesion characteristically associated with paraquat Intoxication and 
Is not actively accumulated into the lung (Rose and Smith, 1977a).
Proposed mechanism of paraquat uptake In lung
Rose jst al. (1974) demonstrated that pulmonary accumulation of
paraquat was an active, energy requiring process. They observed a
14linear accumulation of methyl C-paraquat by rat lung slices from 30 
minutes to two hours of Incubation. The uptake was shown to be 
energy-dependent since KCS plus lodoacetate prevented or Inhibited 
paraquat accumulation when added either at the beginning of, or one hour 
Into, Incubation. Rotenone produced a similar inhibition of uptake. An 
Eadle-Hoffstee plot of their kinetics data indicated that the process
_5
was saturable with an apparent k of 7 x 10 M and V of 300m max
nanomoles paraquat/gram lung/hour.
Rose et al. (1976 ) found that the rate of paraquat accumulation 
into rat lung In vivo was about 1/7 of that predicted by their In vitro 
studies. They attributed the observation to the presence of an 
Inhibitor(s) of paraquat uptake In the circulation. Locke at al.
(1976), subsequently found several endogenous and exogenous compounds 
capable of reducing paraquat accumulation by rat lung slices.
Smith and Wyatt (1981) discovered that the endogenous diamine, 
putrescine, on important modulator of cellular functions, inhibited 
paraquat accumulation by rat lung slices In a concentration dependent
manner. They also found that putresdnp was, itself, accumulated by 
lung slices. In comparing the kinetics of lung accumulation of 
putrescine with those of paraquat, several similarities were 
demonstrated (Smith and Wyatt, 1981). Putrescine uptake was linear, 
reduced with rotenone or KCN plus iodoacetate, enhanced in a sodium-free 
medium, and not Inhibited by ouabain. From their experiments they were 
able to conclude that paraquat is taken up by the lung by a mechanism 
intended for the uptake of endogenous diamines and polyamines. The 
Inhibition of paraquat uptake by lung slices is mediated through 
competition with putrescine at the site of uptake (apparent K^'s of 
uptake - putrescine - 7jiM; paraquat « 70pM).
Paraquat uptake was reduced in lung slices taken from rats 
receiving prior Intravenous paraquat (27 mg/kg) (Smith et al, 1976). 
Evidence of damaged type I and type II alveolar epithelial cells in 
those lungs suggested a major site of paraquat uptake Is the type I and 
II cells. Smith and Wyatt (1981), using the same dosing protocol, 
removed lungs from rats 2 and 24 hours post-paraquat treatment and 
measured uptake of putrescine and paraquat In slices of these lungs. As 
judged by electron microscopy, at two hours there was no evidence of 
damage to the alveolar epithelial cells and also no significant 
reduction in accumulation of putrescine or paraquat. At 24 hours there 
was evidence of morphological damage to these cells and both paraquat 
and putrescine uptake were decreased by approximately 35 percent. These 
results suggested that the population of cells Into which paraquat and
putrescine are accumulated is, at least in part, type I and type II 
alveolar epithelial cells.
In 1982, Smith and Wyatt reported that the polyamlnes, cadaverine, 
spermidine, and spermine are accumulated by lung slices by the same 
mechanism described for putrescine (Smith and Wyatt, 1981). They 
suggested that the reason for pulmonary uptake of paraquat by this 
mechanism is the similarity in the separation of the quaternary nitrogen 
atoms of paraquat and the amino groups of putrescine and other 
polyamlnes. This would require the receptor of the transport mechanism 
to be based on structural elements of a potential transportable 
molecule.
Structure/activity correlation studies of Rosb and Krleger (1981) 
suggest that requirements of a compound to effectively occupy or block 
the receptor mediating this uptake Include (1) two or more positively 
charged nitrogens, (2) maximum positive charge, (3) an apolar group 
which increases lipid solubility, and (4) minimum steric hindrance near 
the nitrogen atoms. Gordonsmlth et al. (1983), using rat lung slices, 
supported these requirements and made the additional generalization that 
for a compound to be an effective inhibitor of the
dlamlne/polyamlne/paraquat uptake system, the two nitrogen-containing 
cationic centers should be separated by at least four methylene groups.
To date, studies on the nature of the pulmonary uptake of paraquat 
have largely been performed using lung slices, an in vitro model with 
clear limitations. In the lung slice systeml normal endothelial 
barriers between circulating paraquat and its purported site of uptake 
(i.e., alveolar epithelial cells) are not intact and paraquat in the
incubaclon medium has free access to the site of uptake. Attempts have 
been made to address this problem via the isolated, perfused lung. 
Rannel'a et al. (1985) corroborated the findings of Forman et al. (1982) 
by demonstrating a biphasic tlme-course of pulmonary accumulation of 
paraquat by perfused rat lungs from the perfusing medium. Phase one 
occurred over the first 60 minutes of perfuBion and was characterized by 
a slow, concentration-dependent accumulation of paraquat into the lung. 
This is believed to reflect passive diffusion of paraquat from the 
perfusate through the endothelium. After 60 minutes the rate of 
paraquat uptake was markedly increased, concentrative in nature, and 
saturable with increasing perfusate paraquat concentrations. The 
Increased rate of uptake was not associated with Increased tissue 
permeability resulting from tissue damage. This second phase of 
paraquat uptake was markedly inhibited by coperfusion with methylglyoxal 
bis(guanylhydrazone) (MGBG), a nonmetabolizable polyamine substrate 
analogue (50:1 - HGBG:PQ). Thus, these data support the occurrence of a 
polyamine-lnhlbitable, active accumulation of paraquat into the Intact 
lung.
It is important to consider that the concentration of paraquat in 
the lung will be determined not only by the rate of accumulation into 
the tissue, but also by the rate of efflux. Putrescine increases efflux 
of paraquat from lung tissue as well as Inhibits its uptake. Lung 
slices taken from rats two hours after dosing with paraquat were 
incubated with putrescine, resulting in a decrease in the half-life of 
paraquat in the lung from 17.2 to 8.6 hours (Smith et al., 1981).
8Importance of putrescine and other polyamlnes In paraquat toxicity
Putrescine Is the first compound formed In the polyamine 
biosynthetic pathway (Figure 2). It Is produced from ornithine via 
ornithine decarboxylase (ODC). Through sequential propylamine additions 
from S-adenosyl methionine, spermidine and spermine are synthesized from 
putrescine.
Although their biochemical function Is not yet understood, a large 
body of evidence Implicates polyamlnes as having a major role in cell 
growth, proliferation, and differentiation (RusBel and Snyder, 1968; 
Heby, 1981; Pegg et al., 1982), and enzyme regulation (Dodds et al., 
1986). Sharp Increases In the activity of ODC and rates of cell 
proliferation are seen with organ growth (Russel and Snyder, 1968); 
wound healing (Mitzutanl et al., 1974), and repair of liver (Katsul et 
al., 1981) and Intestinal mucosa (Luk et al., 1980). The involvement of 
polyamlnes in growth and proliferative functions may be especially 
pertinent with regard to paraquat toxicity because of the Initial 
cellular destruction and the subsequent Interstitial and intraalveolar 
proliferation of fibroblasts. It has even been suggested that 
putrescine may serve as a growth factor for fibroblasts (Ham, 1964; 
Pohjanpelto and Raina, 1972).
In 1982, Khanna et al. demonstrated the ability of putrescine, 
spermidine, and spermine to prevent paraquat-induced lipid peroxidation 
and superoxide dlsmutase induction in incubations of rat lung slices or 
in lungs of rats parenterally dosed with paraquat. They did not relate 
these findings to passible inhibition of paraquat accumulation Into the 
lungs, but explained their results on the basis of "membrane-
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Figure 2. Polyamine Biosynthetic Pathway.
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stabilizing" effects of polyamlnes and/or their superoxide scavenging 
effects (Vanella et al., 1979 and 1980). This potential free radical 
scavenging property of polyamlnes could be of benefit in paraquat 
toxicity.
Exposure of rats to 85X oxygen resulted In a marked elevation of 
lung ODC activity which was maintained through nine days of oxygen 
exposure (Hacker et al., 1983). Lung putrescine content demonstrated a 
similar elevation which also persisted throughout the exposure. Lung 
content of spermidine and spermine were similarly increased, but not 
until later (5 days of exposure).
Thet et al. (1984) investigated alterations in rat lung ODC 
activity and polyamine levels during the repair phase of oxygen-induced 
lung Injury. Immediately post-injury both the activity of ODC and 
levels of putrescine were markedly Increased in lungs. Ornithine 
decarboxylase and putrescine levels continued to rise several days 
post-injury, accompanied by Increased levels of spermidine and spermine 
later in the repair phase, Morphometric analyses showing elevations in 
these parameters during repair could be correlated with a doubling of 
pulmonary endothelial cells and capillary surface area sb well as a 
2.3-fold increase In the number of type II epithelial cells. Treatment 
of rats with dlfluoromethylornithlne, an inhibitor of ODC, resulted in 
suppression of polyamine levels occurring during the repair phase and 
comparably reduced the above morphometric parameters.
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Effects of paraquat in the Isolated, 
perfused rabbit lung
Because of Its ability to produce superoxide radicals with 
resultant Increases in and other toxic oxygen radicals,
paraquat-induced alterations in the redox status of glutathione (GSH - 
reduced; GSSG - oxidized; TLG •* total lung glutathione) in the isolated, 
perfused rabbit lung have been Investigated (Dunbar et al., 1980, 1981, 
1984, and 1985). GSH serves as a major aqueous antioxidant mechanism in 
the cell because of its inherent reducing capacity and its role In the 
GSH peroxldase-enzyme system (Figure 1). The enzymes involved in this 
system are GSH peroxidase which uses GSH as a cofactor in reduction of 
hydrogen peroxide and lipid hydroperoxides, GSSG reductase which reduces 
GSSG back to GSH, and glucose-6-phosphate dehydrogenase (G6PD) which 
supplies NADPH required by GSSG reductase as a source of reducing 
equivalents.
Thirty minute perfusion of Isolated rabbit lungs with paraquat 
results in a significant increase In levels of lung GSSG (Dunbar et al,, 
1984). This paraquat-induced GSH oxidation is potentiated by hyperoxic 
ventilation of the lungs. GSSG efflux, another indicator of oxidant 
stress, is also Increased by paraquat perfusion (Dunbar et^  al., 1984).
Paraquat has been shown to induce activities of pulmonary GSSG 
reductaBe, G6PD (Bus et al,, 1976), and GSH peroxidase (Reddy et al., 
1977) and increase levels of GSH (Keeling and Smith, 1962) in rats. In 
addition to the Increased specific activity of lung G6PD, paraquat 
increases the flux of glucose through the pentose phosphate pathway (the 
rate-limiting enzyme being G6PD) in Isolated rat lungs (Bassett and
12
Fisher* 1978), lung slices (Rose et al.> 1976), and Isolated granular 
pneumocytes (Fisher and Relcherter, 1984). The induction of these 
enzymes has potential importance in augmenting the antloxldant capacity 
of a tissue.
Objectives
There were two major objectives of this research. The first was to 
characterize biochemical effects elicited by prolonged, continuous, 
lov-dose (In terms of rate) paraquat administration on pulmonary 
glutathione status, enzyme activities of the GSH peroxidase antloxldant 
system, and normal lung levels of putrescine, spermidine, and spermine 
In rats.
The effects of this "low-level" paraquat exposure on lung 
glutathione and the glutathione peroxidase antloxldant system should 
have Implications concerning the capacity of the lung to maintain or 
enhance this defense mechanism against a level of paraquat exposure 
which may not be acutely toxic but may carry the potential for damage 
with prolonged exposure. An important question is whether or not the 
lung can maintain this protective mechanism In an induced state. 
Alternatively, will prolonged exposure to even low doses of paraquat 
result in decreased lung glutathione and impairment of the glutathione 
peroxidase system?
Based on what is known about the role of polyamlnes in repair of 
tissue injury, increases in lung polyamine levels resulting from 
exposure to apparently subtoxlc doses of paraquat may suggest the 
occurrence of limited cellular damage that Is manageable by available 
repair mechanisms and, therefore, not manifested as an observable
13
response. As In the case of oxidant protection afforded by the GSH 
peroxidase system, Increased polyamine levels may be associated with 
augmented repair potential until finally the rate of damage exceeds the 
capacity of the repair mechanisms.
The second objective was to determine If coadministration of 
putrescine would result In a decrease in the levels of paraquat detected 
In the lungs at sacrifice. Because of the Importance generally ascribed 
to pulmonary accumulation of paraquat in the realization of its 
toxicity, there could be potential therapeutic benefit In the inhibition 
of paraquat uptake into the lung or increase In Its efflux from the 
lung. Demonstration of decreased lung paraquat levels with putrescine 
coadministration could greatly contribute to this end. Because the 
literature suggests a potential antloxldant effect of exogenous 
putrescine, coadmlnlstratlon of the diamine might provide some direct 
protection to the lungs from paraquat-generated oxidants. This might be 
observable as an attenuation of the biochemical alterations usually 
attributed to paraquat and paraquat-induced production of oxygen 
radicals.
Hypotheses
The study.reported here encompasses three primary hypotheses: (1)
Continuous coadmlnlstratlon of putrescine to rats receiving parenteral 
paraquat will result In a decrease In the concentration of paraquat 
detected In lung tissue. (2) Paraquat will cause alterations in normal 
levels of polyamlnes in the lung in a manner similar to that observed to 
resulting from oxygen exposure and in recovery from oxygen-induced 
pulmonary Injury. (3) Continuous infusion of paraquat at "sub-toxic"
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doses will result In Induction of lung glutathione and the GSH 
peroxidase system.
Chapter 2 
Materials and Methods
Preparation of Treatment Solutions and Osmotic Pumps 
The delivery system for paraquat and putresclne used In this study 
was the Alzet*9, Model 2ML1 osmotic pump (Alza Corporation, Palo Alto,
CA). All pumps used In this experiment were from the same lot (#5258A) 
and provided a pumping rate of 11.5 t 0.3 pl/hr for seven days. The 
filling volume for this lot was 2037 t 34 pi.
Solutions of paraquat (methyl vlologenOH^O - Sigma Chemical, St. 
Louis, MO.; lot #54F-3568) and/or putresclne dlhydrochlorlde (Sigma; lot 
#111F-0106) were prepared In sterile Ringers solution In concentrations 
required to provide the proper dosage based on the delivery rate of the 
osmotic pump. Coadmlnlstratlon of both compounds via one osmotic pump 
was considered acceptable when a solution of paraquat and putresclne 
(approximately 30 and 50 mM, respectively), kept In the dark at 37°C, 
exhibited no apparent degradation of either compound after seven days. 
The concentrations required to provide delivery rates of 250 and 500 
nmoles paraquat/hour were 21.74 and 43.48 mM, respectively. For 
putresclne delivery of 2500 and 5000 nmoles per hour, the respective 
solutions contained 217.39 and 434.78 mM putresclne dlhydrochlorlde. 
After preparation, the solutions were filtered through a 0.2 micron 
filter and stored refrigerated and In the dark.
On the morning of the day the pumps were to be implanted, they were 
filled to capacity with one of the previously prepared solutions of 
paraquat and/or putresclne or with vehicle only for controls. A nine 
centimeter length of sterile vinyl tubing (0.028" I.D. X 0.046" O.D.)
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was attached to the delivery port of each pump* which was then placed In 
Individual test tubes containing 0.92 sterile saline. They were 
Incubated at 37*C for at least four hours as suggested by the 
manufacturer to Insure that the pumps would provide nominal and uniform 
delivery rates immediately after Implant.
Animals and Treatment
Forty-five chronic disease-free, male Sprague-Dawley rats (Charles
River, Wilmington, MA.) weighing from 350 to 400 grams were randomly
divided into nine groups of five animals each. Another group of five
* >
rats was Included in the study to serve as controls for any potential 
decrease in food consumption of the treated animals. Depending on 
assigned treatment group, the rats received one of nine possible dosage 
combinations of paraquat and putresclne. The treatments were comprised 
of either zero, 250 or 500 nmoles paraquat/hour coadministered with 
either zero, 2500, or 5000 nmoles putresclne/hour (Table 1). The route 
of administration was Intravenous via subcutaneously Implanted osmotic 
pumps.
Each day, for five consecutive days, one animal from each of the 
nine treatment groups was anesthetized with five milligrams sodium 
pentobarbital per 100 grams body weight (X.P.). A 1.5 cm Incision was 
made through the skin of the neck and the right, external jugular vein 
exposed by blunt dissection. The vein was ligated cranlally with a 4-0 
silk ligature and cannulated with the primed delivery cannula of Che 
appropriate osmotic pump. The cannula was advanced to the approximate 
level of the right atrium and secured with another silk ligature passed 
around the vein below the point of insertion. The body of the pump was
17
Table 1. Experimental Design
Putrescine Dosage Rate 
(naoles/hr)
Paraquat Dosage Rate 
(nmoles/hr) 0 2500 5000 row n
0 n = 5 5 5 15
250 5 5 5 15
500 5 5 5 15
column n 15 15 15 45
Inserted through the same Incision, advanced over the right shoulder and 
positioned subcutaneously In the subscapular area. This pump placement 
was made via a subcutaneous tunnel formed with the tip of a large, blunt 
hemostat. Following pump implantation, the skin incision vaB closed 
with running, 4-0 nylon suture.
Immediately after pump implant, the rats were weighed and placed in 
individual cages where they were maintained on a 12-hour light/dark 
cycle. Food consumption (Wayne Lab-Blox, Chicago, IL) and animal weight 
and condition were recorded dally for the duration of the exposure 
period of 162 hours (approximately one week). Food consumption of the 
food-limited control (FLO) animals was roughly matched with the average 
daily food consumption of the animals given 500 nmoles paraquat/hour 
which exhibited pronounced anorexia. One rat from each group was 
maintained in a metabolism cage (Bias Labs, Lansing, HI) for the entire 
exposure period to allow collection of total urine output.
Additionally, blood samples (up to one ml) were collected from these 
representative animals at 18, 42, 66, and 114 hours of exposure. The 
samples were collected via tall cut into heparlnized microcentrifuge 
tubes and diluted to twice their volume with isotonic saline to insure 
adequate volume for paraquat and polyamlne measurements. Urine and 
blood samples were stored at -20°C until analyzed.
Sacrifice and tissue preparation
Rats were sacrificed on the seventh day of exposure. The rats were 
anesthetized with sodium pentobarbital as described above and blood 
collected by cardiac puncture into seven ml, heparlnized test tubes.
The blood thus collected was stored at -20°C. The thorax was opened and
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the lungs flushed for 30 seconds with 25 ml Ice cold 0,9% NaCl via a 
catheter placed In the pulmonary artery. The appearance of the lungs* 
liver* kidneys* and heart were noted prior to their rapid removal to 
ice-cold 0.9% NaCl. The organs were blotted and their weight recorded. 
Liver* kidney* and heart were wrapped in aluminum foil* labeled* frozen 
In liquid nitrogen* and stored at -80*C for subsequent biochemical 
analysis.
The basilar half of the right upper lobe of the lungs was placed In 
10% phosphate-buffered formalin which was bubbled with CO,, to promote 
inflation of the specimen. Both hematoxylln-eosln-* and Masson's 
trlchrome-stalned* five micron sections of this lobe were submitted for 
histological evaluation. The sections were coded to insure that the 
examining pathologist was "blind" to treatment group. The remaining 
portion of the lobe was frozen in liquid nitrogen for measurement of 
NADPH.
The remaining lung tissue was rewelghed and homogenized in 10 
volumes of ice-cold 0.1S M NaCl - 0.0S H KH^PO^ pH 7.2, buffer (PBS) 
with a Brlnkmann Palytron (PCU-2-110* Brlnkmann Instruments* Westbury,
NY). Aliquots of homogenate were stored at -20°C for analysis of lung 
polyamines and paraquat, respectively. The remaining lung homogenate 
was diluted with an equal volume of the cold PBS and vigorously 
vortexed. Six ml of diluted homogenate was centrifuged at 23*000 x g 
for 30 minutes at A°C. The resulting post-mltochondrlal (P-M) 
supernatant was used for enzyme analysis. The remainder of the diluted 
lung homogenate was used for glutathione determinations.
Biochemical analyses
All biochemicals used In the following analyses were purchased from 
Sigma Chemical Company (St. Louis, HO). Ornithine (DL-[1-^CJ) was 
purchased from Hew England Nuclear Research Froducts(Boston, HA). 
Scintillation-, and HPLC-grade solvents were purchased from Fisher 
Scientific (Norcross, GA). All other chemicals were reagent grade and 
obtained through various commercial sources.
On the day of sacrifice, one ml of diluted lung homogenate 
(described above) was deprotelnlzed with four ml of 1DZ trichloroacetic 
acid (TCA) for measurement of total lung glutathione (TLG). One ml of 
this homogenate wsb also added to 2.5 mg of N-ethylmaleimide (NEM), 
vortexed, and left at room temperature for one hour to irreversibly bind 
reduced glutathione (GSH). This sample was then deprotelnlzed with four 
ml of 10% TCA for analysis of the unconjugated oxidized glutathione 
(GSSG). Both preparations were centrifuged at 3000 x g for 10 minutes 
and the respective supernatants extracted 10 times with equal volumes of 
water-saturated diethyl ether to remove TCA and excess NEM.
Total glutathione and GSSG were measured. In duplicate, in the 
appropriate samples by the spectrophotometrlc method of Tietze (1969). 
The method measures at 412 nm and 37cC the rate of formation of the 
chromophore, 2-nitro-5-thiobenzoic acid, which results from the reaction 
of S.S'-dithlo-bis-Z-nltrobenzolc acid (Ellman's reagent, DTNB) with 
GSH. This reaction Is coupled to the GSSG reductase-catalyzed reduction 
of GSSG to GSH. The assays were performed In cuvettes containing 1.25 U 
glutathione reductase, 120 pM DTNB, 20 pH NADFH, and 10 - 50 pi of 
tissue prep or standard GSH+GSSG In 1.0 ml of 0.1 M Na/K phosphate, 5.0
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mM EDTA buffer, pH 7.S. Under these conditions the rate of chroraophore 
production was proportional to the amount of GSH and GSSG present In the 
reaction mixture. Kates were recorded against a sample blank and GSH 
and/or GSSG content calculated by comparison to a standard curve.
The activity of ornithine decarboxylase (ODC) van determined In 
triplicate within three hours of sacrifice by the method of Russel and
Snyder (1968) as modified by Lau and Slotkln (1979). This method
14 14measures the amount of CO^ liberated by ODC from dl-1- C-ornlthine.
A 0.9 ml aliquot of the lung P-M supernatant was incubated with 1.8 mM
dithlothreltol and 50 pM pyrldoxal phosphate (1.0 ml total volume) In a
25 ml Erlenmeyer flask equipped with a rubber stopper supporting a
suspended polyethylene center well (Kontes Glass, Vineland, NJ). The
center well contained 0.6 ml hyamine hydroxide (1.0 M  In methanol) to 
14
absorb liberated CO^.
The flasks were agitated for ten minutes at 37°C in a shaking water
14bath. After thlB equilibration period, 0.5 uCi of DL-l- C-omithlne
(specific activity 57.6 mCl/mmole) substrate was Injected into the
system via a stoppered sidearm of the flask (final ornithine
concentration - 10.5 pM). The flasks were agitated for 30 minutes,
after which time 1.0 ml of 2.0 M citric acid was injected through the
Bidearm to stop the reaction. The mixture was shaken another 30 minutes
14at 25"C to allow complete absorption of CO^ by the hyamine hydroxide.
The center wells were removed from the flasks and placed In glass 
scintillation vials containing 15 ml of 0.42 2,4-diphenyloxazole and 
0.01% B~bls-(2-phenyloxazole) benzene in scintillation grade toluene.
The vials were then assayed for radioactivity In a liquid scintillation
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spectrometer (Beckmann, Model LS 9800). A TCA-injected enzyme blank was
Included In each assay run to determine radioactivity from
14non-enzymatlcally liberated CO^ or other sources. Background counts 
were also made In vials containing only scintillation fluid. Counts 
were converted to dlslntlgrations per minute (corrected for quenching) 
and ODC activity reported as pmoles liberated/lung/hour.
The activities of glucose-6-phosphate and 6-phosphogluconate 
dehydrogenase (G6PD and 6PGD), GSSG reductase (GR) and glutathione 
peroxidase (GP) were measured spectrophotometrically, In duplicate, at 
37°C in the lung P-M supernatant by recording changes In 340 nm 
absorbance of the appropriate reaction mixture. The absorbance change 
wsb due to the rate of reduction of NADP by G6PD and 6PGD (Beutler,
1975) or oxidation of HADFH by GR (Horn, 1965) and GP (Little et al., 
1970). The activities were calculated using the molar extinction 
coefficient of NADF(H) at 340 nm (6.22 x 10^).
The colorimetric method of Slater and Sawyer (1962) was employed 
for measurement of lung NADPH. Portions of rat lung (100-300 mg) that 
had been previously frozen in liquid nitrogen were homogenized In hot 
0.05 M HaOH containing 0.42 mM tryptophan to prepare a 12.52 (w/v)
homogenate and boiled for 2 minutes. The samples were then Iced for 15
minutes and neutralized with 1.0 M  Kl^PO^, followed by centrifugation 
at 4°C for 30 minutes. Aliquots (0.05-0.10 ml) of the clear supernatant 
were plpeted into 1 cm u.v.quartz cuvettes containing 30 uM 
dlchlorophenol-lndophenol (diluted from 1.75 mgZ stock solution prepared 
fresh each day). Additionally, each cuvette contained 2 mM
glucose-6-phasphate, 65 pM phenazine methosulfate, and 0.15-0.20 ml of
0.1 M Trls buffer, pH 8.0. The contents were mixed and the absorbance 
changes at 600 nm followed for a period of five to ten minutes, until a 
stable baseline was obtained. Three-tenths unit of G6P0 was then added 
and the resultant rate of absorbance change (linear for 2-4 minutes) was 
compared to that obtained with 100, 200, or 500 pmole standards of 
NADPH. The amount of NADPH present In the sample aliquot was converted 
Into NADPH/lung by using a correction factor dependent upon the total 
volume of neutralized NADPH homogenate prepared and the ratio of total 
lung weight to the weight of the sample homogenized, as given above.
Paraquat was measured, In duplicate, spectrophotometrlcally In 
blood, urine, and tissue homogenates by modifications of the method of 
Knepll (1977). For determination of paraquat In urine, 20 pi of urine 
was diluted to 2.0 ml with water. To the dilute urine was added 0.2 ml 
of alkaline dlthlonlte solution (0.2 g sodium dlthlonlte In 10 ml 1.0 N 
NaOH). The resulting blue color was read at 396 nm against a blank 
without alkaline dlthlonlte. Urine paraquat was calculated by comparison 
to a paraquat standard curve prepared from serial dilution of paraquat 
In water with concentrations encompassing the range of diluted samples 
(0.5 pg/ml - 8.0 pg/ml).
For analysis of blood paraquat, one ml of blood and one ml of water 
were added to 2.0 ml chlorofornwethanol (4:1,V:V) and vigorously mixed. 
To this mixture was added 1.2 g ammonium sulfate followed by additional 
mixing. The deprotelnlzed blood extracts were then centrifuged at 3000 
x g for 10 minutes. Alkaline dlthlonlte (0.1 ml) was added to one ml of 
the supernatant and the absorbance recorded versus supernatant without 
dlthlonlte. The calibration curve was constructed from standard
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solutions of paraquat (0.5 pg/ml - 4.0 pg/ml) prepared in control rat 
blood.
To determine paraquat in lung, 2.0 ml of the previously prepared 
10Z lung homogenate vaa mixed with 2.0 ml of chloroform:ethanol and 1.2 
gm ammonium sulfate and centrifuged at 3000 x g for 10 minutes.
Paraquat was measured in the supernatant as described above for blood.
The calibration curve was performed in pooled, control lung homogenates 
spiked with paraquat concentrations of 0.5 - 8.0 pg/ml.
Paraquat levels were determined in like manner in PBS homogenates 
of liver, kidney (0.3-0.6 g tissue/ml), and heart (0.2 g tissue/ml) with 
paraquat standard curves constructed from the respective, 
paraquat-spiked, tissue homogenates from control animals.
Dansylatlon of the urine and tissue samples for HPLC analysis of 
polyamines was carried out, in duplicate, by the method of Fleishcer and 
Russell (1975). One ml of a 20-fold diluted urine sample, one ml of 
blood (125 pi in serial blood samples), and samples of tissue 
homogenates containing approximately 200 mg tissue (in 0.5 - 2.0 ml 
homogenate) were deprotelnlzed with perchloric acid (PGA) to provide a 
final 0,2 H PCA concentration. Forty nmoles of dlethylamine (DEA) were 
added as an Internal standard to each sample. After vigorous mixing the 
deprotelnlzed samples were centrifuged at 3000 x g for 10 minutes. A 
known volume of the resulting supernatant was transferred to tubes and 
dansyl chloride in acetone (2.7 mg/ml) was added in the amount of 0.25 
ml/ml supernatant. The pH of the dansylatlon mixture was adjusted to 
9.0 ± 0.5 with saturated sodium carbonate (200 - 400 pi, depending on
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sample volume). The samples were then Incubated In the dark at room 
temperature for four hours.
Following the Incubation period, the acetone was evaporated under 
a stream of nitrogen and the sample extracted with 2.0 ml benzene. The 
mixtures were centrifuged (3000 x g, 10 minutes) and 0.4 ml of the 
benzene layer removed and placed In HFLC sampling vials. The benzene 
was evaporated to dryneas overnight and then reconstituted with 2.0 ml 
of HPhC grade chloroform.
Standards of putresclne dlhydrochlorlde, spermidine, 
trlhydrochlorlde, and spermine tetrahydrochlorlde containing 
concentrations of from one to 200 nmoles of each compound/ml plus 40 
nmoles DEA/ml were prepared and dansylated by the same method.
Standards and samples were treated Identically throughout this 
derlvatizatlon process.
Analysis of the fluorescent, dansylated polyamine standards and
TM
tissue preps were performed on a Waters (Milllpore Corporation,
Milford, MA) HPLC system equipped with an automatic sampler (WlBp^*
710B). The solvent system used consisted of chloroform:Isopropanol
(100:1) (both HPLC grade) with solvent flow maintained at one ml/mlnute.
TM TM v TM
A Waters pPoraail column (8 mm x 10 cm) in a Waters Radial
Compression Module (RCM-100®) was uBed for separation of the polyamlne
TM
derivatives. Eluted peaks were detected by a Waters Model 420 
Fluorescence Detector equipped with a 365 nm bandpass filter for 
excitation and 495 nm longpass filter for emission wavelengths.
Protein measurements were made by the method of Lowry et al (1951).
Statistical analyses of the data was by two-way Analysis of 
Variance. Upon detection of a treatment resulting in significantly 
different data, a Duncan's Multiple Range test was used for comparison 
of treatment group means. These analyses were performed using the 
Statistical Analysis System (SAS)C software (SAS Institute, Inc., Cary, 
NC). Comparisons of data obtained from Food-limited Control (FLC) 
animals with that of other treatment subgroups were performed by 
Student's t-test.
CHAPTER 3 
Results
Animal condition, body weights, and food consumption during
Infusion period
All animals except for those receiving high-doae (300 nmoles/hour) 
paraquat (H1FQ) tolerated their respective treatment combinations veil, 
as judged by behavior and outward appearance. Rats given either zero 
(OPQ) or low-dose (250 nmoles/hour) paraquat (LoFQ), regardless of 
putresclne dosage, appeared healthy, had comparable food consumption 
(Figure 3), maintained or had slight increases In their body weight 
(Figure 4), and seemed to exhibit normal activity throughout the almost 
seven days (approximately 162 hours) of paraquat and/or putresclne 
Infusion.
As a group, however, rats administered H1PQ began to show outward
signs of distress, generally between the fourth and fifth day of
exposure. This usually began as a dark, crusty discharge around the
nose, progressing to rapid, shallow breathing, lethargy, and decreased
food consumption. Animals most affected appeared emaciated and pale with
some indication of cyanosis by the end of exposure. Food consumption
had ceased; there was little voluntary activity; breathing was rapid,
shallow, and obviously labored; and some exhibited piloerection.
Throughout the period of Infusion there was a progressive decrease in
body weight In these animals (Figure 4). Food consumption was lower in
the HiPQ groups compared to other treatments beginning between day two
and three with a more marked decline In mean food consumption beginning
between days four and five (Figure 3).
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Figure 3. Daily Food Consumption 
Mean daily food consumption (grams) ± standard deviation of rats 
given no paraquat (o) (n“15), 250 nmoles paraquat/hour (o) (n“15), 500 
nmoleB paraquat/hour (•) (n"14), and food limited control (FLC) animals 
(x) (n“5). There was no variation in food consumption of the FLC animals 
since they ate all the food made available to them. These data are 
presented as a function of paraquat dosage only since putrescine 
administration had no effect on food consumption.
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Figure 4. Daily Changes in Rat Body Heights 
Hean daily body weight as percentage of pre-operative weight ± 
standard deviation in rats-given no paraquat (o) (n«15), 250 nmoles 
paraquat/hour (e) (n*«15)( 500 nmoles paraquat/hour (•) (n“14), and food 
limited controls (FLC) {*) (n**5). These data are presented as a function 
of paraquat dose only since putrescine administration had no effect on 
food consumption.
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Due to the extremely poor appearance (at day five) of one animal in 
both the 500 nmoles paraquat/hour + zero putresclne (OFTC) and 500 
nmoles paraquat + 5000 nmoles putrescine/hour (UiPQ + HiPTC) subgroups* 
one additional rat was added to both groups in an attempt to assure 
survival of five animals per treatment group.
Two animals in the K1PQ +  OPTC group were found dead before 
conclusion of the exposure period; one on the sixth and one on the 
seventh day of exposure* leaving four surviving animals in this group. 
Necropsy of the spontaneously-dying animals revealed pleural effusion 
fluid (approximately one to two ml) in the thoracic cavity and lungs 
which were large, plum colored, and resistant to collapse. The relative 
weights (organ weight/body weight x 100) of the lungs of these two 
animals were increased to 1.56 and 0.81* respectively ( compared to 0.27 
+ 0*03 in the OPQ +  OPTC group). Compared to control (i.e., the OPQ + 
OPTC group) the relative weights of livers, kidneys, and hearts of the 
respective dead animals were Increased 4.27 and 31.87, 51.97 and 54.37* 
and 130.07 and 33.37, respectively.
One of the animals in the H1PQ + U1PTC treatment group died between 
day six and seven of exposure. The organs appeared as described above. 
The relative lung weight was Increased to 1.46 (4417 of control) and the 
relative weights of liver, kidney, and heart were also Increased 25.47* 
75.37, and 143.07 over control, respectively.
Food consumption in the Food-limited Control group (FLC) was 
maintained at a steadily decreasing level In on attempt to roughly match 
the highly variable food consumption observed in the HiPQ groups (Figure 
3). The body weight loss of the FLC animals reflected their impaired
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nutritional status and was slightly greater, on average than that of the 
HiFQ animals (Figure 4).
Dally paraquat and putresclne concentration in blood and 
urine of representative animals from each treatment group 
Figure 5 shows the blood paraquat concentration at approximately 
18, 42, €6, 114, and 162 hours, post-pump Implant, In rats maintained In 
metabolism cages and administered paraquat. The blood levels Indicated 
that paraquat was maintained at steady blood concentrations by the 
method and route of administration employed In this study. In these 
representative animals, those given LoPQ, regardless of putresclne 
dosage, maintained mean blood levels of paraquat which ranged from 0.82 
± 0.23 to I.52 ± 0.17 nmoles paraquat/ml blood (n-3). Blood 
concentrations of paraquat In the animals administered H1PQ were 
maintained, as expected, In a range double that measured In the LoPQ 
animals [2.36 (n-1) to 3.03 + 0.69 (n**3) nmoles paraquat/ml blood]. As 
In the LoPQ animals, putresclne administration had no effect on blood 
paraquat concentration In animals given H1PQ.
The average putresclne blood level maintained In each of the 
representative animals was, also, reflective of administered dose (Table 
2). However, the animal representing both the UiPQ + OPTC and H1PQ + 
H1PTC groups showed great variability in this data primarily due to one 
outlying data point. Putresclne analysis In these temporal blood 
samples did not appear to provide the same sensitivity as the terminal 
blood samples, as evidenced by lack of detection of putresclne in OPTC 
animals.
uto
Figure 5. Temporal Blood Paraquat Concentration 
Blood paraquat concentrations (nmoles/ml ± standard deviation) in representative animals given 
500 nmoles paraquat/hour (*) (n=3) were maintained at significantly higher levels (P <0.05 by Student's 
t-test) than those given 250 nmoles paraquat/hour (o) (n*3). There were no differences in blood 
concentration of paraquat with putrescine coadministration, therefore, the data points represent the mean 
standard deviation of the three animals given the stated dose of paraquat regardless of which of the three 
different levels of putrescine was administered (i.e., 0, 2500, or 5000 nmoles/hour).
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Table 2. Averge Daily Blood Putrescine Concentration*
Putrescine Dosage Rate 
(nmoles/hr)
Paraquat Dosage Rate 
(nmoles/hr) 0 2500 5000
0 ND 3.93 + 1.65 
(5)
15.41 ± 17.95a 
(5)
250 ND 4.59 ± 0.66 
(4)
8.44 ± 1.53a 
(5)
500 ND 5.66 + 2.30 
(5)
29.22 ± 33.39 
(4)
*Data are expressed as average daily blood putrescine 
concentration (nmoles/ml) in individual rats for the duration of 
treatment±standard deviation. Numbers in parentheses indicate number 
of daily determinations comprising the average.
aThe high standard deviation in these animals can be accounted 
for by one out-of-range data point in each group.
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Daily urinary excretion of both paraquat and putrescine 
demonstrated a steady, dose-dependent elimination of both compounds 
(Figure 6), There was no apparent effect of one compound on the urinary 
excretion of the other in these representative animals. The total 
urinary excretion of paraquat in these animals amounted to 81 + 18%
(n**3) and 78 + 8.0% (n**3) of administered dose for LoPQ and H1PQ groups, 
respectively. Total urinary excretion of putrescine represented only 13 
± 4.0% (n-3) and 11 t 3.0% (n**3) of the total administered putresclne
in animals given LoPTC (2500 nmoles/hour) and H1PTC (5000 nmoles/hour), 
respectively. Since putrescine is an endogenously produced compound, 
not all of the excreted putresclne could be attributed to that which was 
administered. In animals not given putresclne the total urinary 
putresclne excretion reached approximately 20 nmoles by the end of the 
exposure period.
Body and organ weights and gross pathology 
Regardless of putresclne dosage, the body weights of LoPQ and UIPQ 
rats, at sacrifice, proved to be 93.7% and 78.5% (F<0.05), 
respectively, of rats given OPQ (Figure 7). The apparent decrease seen 
in the LoPQ group was not a true decrease because the average 
preoperative weight of these animals was 95.7% (P<0.05) of the rats 
assigned to the OPQ group. The average terminal body weight of the FLC 
animals waB 76.8% of the OPQ group (P< 0.05) which was similar to the 
weight loss in the H1PQ animals.
Upon termination, the organs of all animals except those receiving 
H1PQ appeared normal. The lungs from the H1PQ group exhibited varying 
degrees of hemorrhage ranging from scattered focal hemorrhage to
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Figure 6, Cummulative Urinary Excretion of Paraquat and Putrescine 
Data are expressed as pmoles paraquat ± standard deviaton. Paraquat 
in the urine of animals given 250 nmoles paraquat/hour (o) (n"3) and 500 
nmoles paraquat/ hour (•) (n“3, except day seven when n*2) indicated the 
occurance of steady, dose-dependent excretion with no apparent effect 
due to coadministered putrescine. Likewise, putrescine administration 
[either 2500 nmoles/hour <a ) (n“3) or 5000 nmoles/hour (A) (n=3)l 
resulted in a dose-dependent and steady urinary excretion of putrescine 
which was greater than basal putrescine excretion observed in animals 
not given putrescine (®) (n“2, except day seven when nBl). There was no 
observable effect on putrescine excretion due to paraquat 
coadministration.
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Figure 7. Rat Body Weights at Termination 
Data are expressed as grams body weight + standard deviation. Groups coded with the same letter were 
not significantly different (i.e., F > 0.05) by Two-way ANOVA and subsequent Duncan's Multiple Range Test. 
The FLC group mean was compared to other group means by Student's t-test. The apparent significant decrease 
in body weight in the 250 nmoles paraquat/hr (LoPQ) groups was not a true decrease since the pre-operative 
weights of these animals were also significantly lower than the animals given no paraquat (OFQ). Sample 
sizes: n“5 per subgroup except in the 500 nmoles paraquat/hr + OFTC group (n“4).
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occasional involvement of entire lobes. The lungs were significantly 
larger (P<0.05) than lungs from animals given either OPQ or LoPQ as 
evidenced by greater than doubled relative weights (I.e., organ 
weight/body weight x 100) shown In Figure 8. This weight gain was 
indicative of Injury which could be associated with varying degrees of 
edema, hemorrhage and vascular congestion, and/or cellular 
proliferation.
Despite the normal appearance of the other organs examined, there 
were some significant (P<0.05) changes observed In the relative weights 
of liver and kidney as a result of paraquat treatment (Table 3). The 
relative liver weight In LoPQ animals was 1092 and 1122 (P< 0.05) of 
HiPQ and OPQ groups, respectively. In the FLC group, relative liver 
weight was significantly decreased (P<0.05). Relative liver weights of 
the HIPQ groups, were not different from those of animals not given 
paraquat. The relative kidney weights of LoPQ and HIPQ rats Increased 
to 1102 and 1162 of the OPQ groups, respectively, while relative heart 
weights were not different In any treatment group (Table 3).
Evaluation of hlstopathology by light microscopy
Qualitative examination of lung sections by light microscopy 
revealed that lungs of rats given HIPQ had undergone changes 
characteristic of paraquat Intoxication (Figure 9). Coadministration of 
putresclne offered no apparent modulation of these histological changes. 
Further, putresclne administration alone had no observable effect of 
lung histology. Lungs of control, LoPQ, or FLC animals were, also, 
unremarkable.
LO03
Figure 8. Relative Lung Weights 
Data are expressed as the average of lung weight/body weight x 100 [+ standard deviation]. Groups coded 
by the same letter were not significantly different (i.e., P > 0.05) by Two-way AN0VA and subsequent 
Duncan's Multiple Range Test. The FLC group mean was compared to other group means by Student's t-test.
There was no difference in relative lung weights due to putrescine administration. Absolute lung weights 
were 1.15 - 0.12, 1.21 ± 0.16, 2.26 - 0.78, and 1.13 ± 0.05 grams for groups given OPQ, LoPQ, HiPQ, and FLC 
group, respectively. Sample sizes: n“5 per subgroup except in the 500 nmoles paraquat/hr + 0PTC group (n=4).
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Table 3. Relative Weights of Liver, Kidney, and Heart*
Paraquat Dosage Rate (nmoles/hr)
Organ 0 250 500 FLC
Liver 3.11 ± 0.15a 
(15)
3.37 ± 0.24b 
(15)
3.14 ± 0.40a 
(14)
2.92 ± 0,17c 
(5)
Kidney 0.79 ± 0.03° 
(15)
0.87 ± 0.10b 
(15)
0.98 ± 0.17b 
(14)
0.78 ± 0.06a 
(5)
Heart 0.29 ± 0.01a 
(15)
0.31 ± 0.03a 
(15)
0.31 ± 0.03a 
(14)
0.30 ± 0.01a 
(5)
*Data are expressed as the average of organ weight/body weight x 100 
for each paraquat group across all putresclne dosages ( ±standard 
deviation). Groups coded by the same letter were not significantly 
different (i.e., P >0.05) by Two-way ANOVA and subsequent Duncan"s 
Multiple Range Test. There were no significant differences due to 
putresclne dosage.The FLC group mean was compared to other group means by 
Student’s t-test. Numbers in parentheses indicate sample size.
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Figure 9. Section of Control and Paraquat-damaged Lung 
As judged by light microscopy, the lungs of LoPQ, FLC, and control 
(A) rats were unremarkable. In the lungs of rats given HiPQ (B) the 
walla of the respiratory bronchioles, alveolar ducts, and alveoli were 
estimated to be two to three times their normal thickness, at least 
partially attributable to interstitial pulmonary edema. Other, 
trichrome-stained, sections confirmed an increase in collagen 
deposition, suggesting stimulation of fibroblasts. Characteristic damage 
to the type I alveolar epithelial cells was evidenced by proliferation 
of type II alveolar epithelial cells which lined many of the alveolar 
spaces. Pulmonary macrophages were increased in number, and some alveoli 
contained cellular debris. There also appeared to be a Blight increase 
in numbers of chronic inflammatory cells along with variable numbers of 
red blood cells in the interstitium. (hematoxylin & eosin; x400)
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Paraquat and polyamlne concentrations of blood 
at termination
Blood paraquat levels at sacrifice were significantly different due 
to paraquat dosage (P< 0.05) with animals given HIPQ having slightly 
more than twice the paraquat concentration of the LoPQ groups (Figure 
10). These blood concentrations ranged from 1.06 to 1.57 nmoles/ml for 
LoPQ groups and from 2.09 to 4.87 nmoles/ml for HiPQ groups and were 
comparable to the paraquat levels shown to be maintained In 
representative animals over the duration of paraquat infusion (compare 
Figure 5). Coadministration of putresclne had no effect on blood 
paraquat concentrations.
While putresclne infusion did result In a dose-dependent Increase 
In blood putresclne concentration In the terminal blood samples, 
coadmlnlstratlon of paraquat resulted In statistically significant (P < 
0.05) interactive effects between putresclne and paraquat (Figure 11). 
Increasing, combined doses of paraquat and putresclne appeared to 
potentiate blood putresclne levels over the Increases in blood 
putresclne produced by either compound alone.
Blood spermidine was significantly decreased due to paraquat 
Infusion over all doses of putresclne (Figure 11). These decreases 
amounted to 31Z and 39Z for LoPQ and HIPQ, respectively and were not 
significantly different from each other. Putresclne administration also 
had an effect on blood spermidine In that across all paraquat doses■ 
HiPTC resulted In a 34% Increase compared to animals given OFTC. The 
largest decrease in blood spermidine was observed In the FLC group
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Figure 10. Terminal Blood Paraquat Concentration 
Data are expressed as nmoles paraquat/ml blood + standard 
deviation. Groups coded by the same letter were not significantly 
different (i.e., P >0.05) by Two-way ANOVA. There were no differences 
due to putrescine coadministration. Sample sizes: n**5 per group except 
in the 500 nmoles paraquat/hr + 0PTC group (n"4)•
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Figure 11. Terminal Blood Polyamine Concentration
Data are expressed as nmoles polyamine/ml blood + standard deviation. For each polyamine, groups coded 
with the same letter were not significantly different (i.e., P > 0.05) by Two-way ANOVA and subsequent 
Duncan's Multiple Range Test. The FLC group means were compared to other appropriate group means by 
Student's t-test.
* Two-way ANOVA revealed significant interaction effects of coadministered paraquat and putrescine on 
blood levels of putrescine and spermine.
Sample sizes: n°5 per subgroup except in the 500 nmoles paraquat/hr + OPTC subgroup (n“4).
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(Figure 11). The blood spermidine concentrations in this group were 
29.2Z, 42.41, and 48.7% of OPQ, LoPQ, and HiPQ groups, respectively.
Statistical analysis revealed significant interactive effects (P < 
0.05) of paraquat and putrescine on blood spermine levels (Figure 11).
In the absence of paraquat, putresclne administration seemed to Increase 
blood spermine levels. Animals given LoPQ also appeared to have 
Increased blood concentrations of spermine. Putresclne coadministration 
to this group did not cause any further Increases in this polyamine in 
contrast to the situation in animals receiving OPQ. Blood spermine in 
the HiPQ groups shoved a generalized decrease compared to the respective 
OPQ and LoPQ groups.
Normalization of lung biochemical data 
Lung injury typically involves congestion, hemorrhage, accumulation 
of edema fluid containing varying amounts of protein, and cellular 
proliferation. All of these factors can contribute in varying degrees 
to large Increases in lung weight and protein content which can make 
expression of data aa value per gram tissue or per mg protein subject to 
large errors. Because of the large increases in lung weight and total 
lung protein (Figure 12) observed in the HiPQ groups, all lung 
biochemical data was expressed as value per whole lung (i.e., both 
lungs) in order to normalize this data to a common denominator term.
Paraquat and polyamine content in the lungs at sacrifice 
The paraquat content per lung (Figure 13) reflected the 
administered dose of paraquat and averaged 24.52 ± 4.72 and 55.27 ± 8.9 
nmoles/lung in the LoPQ + OPTC and HiPQ + OPTC groups, respectively.
Figure 12. Lung Frotein Content 
Data are expressed both as mg protein/gm tissue and mg protein/lung + standard deviation. Groups coded 
with the same letter were not significantly different (i.e., P > 0.05) by Two-way AHOVA and subsequent 
Duncan's Multiple Range Test. The FLC group mean was compared to other group means by Student's t-test. 
There were no significant differences due to putrescine coadministration. Sample sizes: n“5 per subgroup 
except in the 500 nmoles paraquat/hr + OPTC subgroup (n*4).
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Figure 13, Lung Paraquat Content 
Data are expressed as nmoles paraquat/lung + standard deviation. 
Groups coded with the same letter were not significantly different 
(i.e., P >0.05) by Two-way AHOVA and subsequent Duncan's Multiple Range 
Test. There were no differences due to putrescine administration. Sample 
sizes: n“5 per subgroup except in the 500 nmoles paraquat/hour + OPTC 
subgroup (n°4).
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Further, these lung paraquat levels were higher than the respective 
blood levels on the basis of a gram lung to milliliter blood comparison, 
suggesting the occurrence o£ concentratlve uptake. Coadministration of 
putresclne at either dosage rate had no significant effect on lung 
paraquat content In animals given LoPQ or HiPQ.
A profile of lung polyamine content is given in Figure 14. The 
administration of H1PTC resulted In a 57% increase (P<0.05) In lung 
putresclne levels over those measured In animals of all treatment groups 
given OPTC. The LoPTC dose was not effective In Increasing lung 
putresclne concent except In the HIPQ -f LoPTC group. In that group, 
LoPTC administration resulted In a statistically Insignificant, 27% 
Increase In lung putrescine.
Although the effects of coadministered putresclne on lung paraquat 
were not statistically significant, paraquat had marked effects on the 
levels of lung putrescine and spermidine (Figure 14). With HIPQ, lung 
putrescine was Increased by 307% (P<0.05), 167% (P<0.05) and 621% (P< 
0.05) over levels found In OPQ, LoPQ, and FLC groups respectively. HiPQ 
resulted in a 59% (P< 0.05), 97% (P<0.05), and 164% (F<0.05) Increase 
in lung spermidine compared to OPQ, LoPQ, and FLC groups, respectively. 
The lungs of animals given HIPQ demonstrated a 73% (P< 0.05) increase in 
pulmonary OSC activity as compared to both OPQ and LoPQ animals (Figure 
15). Putresclne coadministration had no effect on lung 0DC activity.
Paraquat and polyamines In liver, kidney, and heart 
The paraquat content of liver and kidney (Figure 16), though leas 
than that of lung (compare Figure 13), showed a definite 
dose-dependency. Paraquat levels per dose were greatest In kidney and
Figure 14. Lung Polyamine Profile
Data are expressed as nmoles polyamine/lung + standard deviation. For each polyamine, groups coded with 
the same letter were not significantly different (i.e. P > 0.05) by Two-way AHOVA and subsequent Duncan's 
Multiple Range Test. The FLC group means were compared to other group means by Student's t-teat.
* Lung putrescine content was significantly elevated (P < 0.05) over all levels of paraquat dosage by 
coadministration of 5000 nmoles putrescine/hr.
** Lung putrescine content was significantly lower (P < 0.05) in the FLC group than in animals 
administered paraquat.
*** Lung spermidine and spermine content of the FLC group was significantly lower (P < 0.05) than that 
of animals administered 500 nmoles paraquat/hr (HiPQ).
Sample sizes: ns5 per subgroup except in the 500 nmoles paraquat/hr + OPTC subgroup (n**4).
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Figure 15. Lung Ornithine Decarboxylase Activity 
Data are expressed as pinoles liberated/lung/30 min. at 37° C + standard deviation. Groups coded
with the same letter were not significantly different (i.e., P >0.05) by Two-way ANOVA and subsequent 
Duncan's Multiple Range Test. The FLC group mean was compared to other group means by Student's t-test. 
There were no significant differences due to putrescine coadministration. Sample sizes: n=5 per subgroup 
except in the 500 nmoles paraquat + OPTC subgroup (n*4).
PUTRESCINE DOSAGE RATE
( n m o l e s / h r )
0 n  2500 EZ35000 M
0 250 500
PARAQUAT DOSAGE RATE ( n m o l e s / h r )
v>o
Figure 16. Kidney and Liver Paraquat Content 
Lata are expressed a3 nmoles paraquat/gm tissue + standard deviation. For each organ, groups coded with 
the same letter were not significantly different (i.e., P > 0.05) by Ttao-way ANOVA and subsequent Duncan's 
Multiple Range Test. There were no significant differences due to putrescine coadministration. Sample sizes: 
n=5 per subgroup except int the 500 nmoles paraquat/hr + OPTC subgroup (u"4).
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undetectable In heart homogenates. Coadministration of putresdne at 
any dose had no effect on paraquat levels In kidney and liver.
In the liver and kidneys, there was no significant difference in 
concentration of any of the three measured polyamines between any of the 
primary treatment groups (Appendix).
In the heart, putrescine administration significantly Increased the 
putresclne concentration of the tissue (to 118X and 125Z of OFTC for 
LoPTC and HiPTC, respectively) but there was no significant difference 
In this increase due to difference In putresclne dose (Figure 17). 
Putrescine administration had no effect on the heart concentration of 
any other polyamine.
It Is also shown In Figure 17 that putresclne concentration in 
heart tissue was significantly elevated (F< 0.05) by HiPQ an average of 
28Z and 23Z over OFQ and LoPQ respectively. Both doses of paraquat 
tended to significantly decrease spermine concentration (79X and 81Z of 
the OFQ groups In the LoFQ and HIPQ groups, respectively).
Changes In lung glutathione, glutathione peroxidase system
enzymes, and NADPH
Over all dosage levels of putrescine, the LoPQ treatment groups 
demonstrated an elevation of total lung glutathione (TIG " reduced (GSH) 
+ oxidized glutathione (GSSG)] to 134X (P< 0.05) of that measured in 
animals not administered paraquat (Figure 18). TLG levels from animals 
which were given HiPQ were not different from the OPQ groups but were 
125JE (P< 0.05) of that measured in the FLC group (Figure 18).
The increased TLG reported In Figure IB is essentially attributable 
to increased lung GSH since there w o b no significant change in lung GSSG
Figure 17. Heart Polyamine Profile
Data are expressed as nmoles polyamine/gm tissue + standard deviation. For each polyamine, groups coded 
with the same letter were not significantly different (i.e. P > 0.05) by Two-way ANOVA and subsequent 
Duncan's Multiple Range Test. The FLC group means were compared to other group means by Student's t-test.
* Duncan's Multiple Range Test indicated that all paraquat doses, the putrescine levels in the heart 
were significantly increased in the animals that were administered putrescine. This effect was not dependent 
on putrescine dose.
Sample sizes: n“5 per subgroup except in the 500 nmoles paraquat/hr + OPTC subgroup (n*4).
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Figure 18. Total Lung Glutathione Content 
Data are expressed as pmoles total glutathione (reduced + 
oxidized)/lung + standard deviation. Groups coded with the same letter 
were not significantly different (i.e., P > 0.05) by Two-way ANOVA and 
subsequent Duncan's Multiple Range Test. The FLC group mean was compared 
to other group means by Student's t-test. There were no differences due 
to putrescine coadministration. Sample sizes: n**5 per subgroup except in 
the 500 nmoles paraquat/hr + OPTC subgroup (na4).
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resulting from paraquat exposure (Figure 19). Putrescine, likewise had 
no effect on lung GSSG at any dose.
Of the four glutathione peroxidase system enzymes measured in the 
lungs, activities of two were not affected by any treatment. These were 
6-PGD and GSH peroxidase (Appendix). Glucose-6-phosphate dehydrogenase 
(Figure 20) and GR (Figure 21), however, demonstrated significant 
treatment-induced alterations in activity.
The total activity of G6PD in lung showed a paraquat dose-dependent 
induction. The activity of LoPQ and HiPQ groups increased to 1131 and 
159% of control, respectively across all putresclne doses. The 
induction of lung G6FD in the HIPQ groups is especially significant 
because it was 266Z of the activity measured in the comparably fed, FLC 
group which showed significant loss of G6PD activity. Putrescine 
administration had no effect on G6PD activity.
Total lung GR activity was also Induced by paraquat administration. 
However, the LoPQ groups demonstrated a greater increase (132Z of OFQ 
groups) in lung GR activity than did the animals in the HiPQ groups 
(117% of OPQ groups). As with G6PD, GR activity was not altered by 
putresclne administration.
• Administration of paraquat resulted in a dose-dependent decrease in 
NADPH, irrespective of putresclne dosage (Figure 22). The large 
standard deviations of group means probably precluded detection of 
significant differences in lung NADPH between OPQ and LoPQ groups (NADPH 
in the LOPQ groups was 82% of OPQ). Despite the high variation the 
decrease in lung NADPH observed in the HIPQ animals (57% of OPQ groups) 
was statistically significant (P<0.05).
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Figure 19. Lung Oxidized Glutathione Content.
Data are expressed as pmoles GSSG (as GSH equivalents)/lung + 
standard deviation. There were no significant differences due to any 
treatment. Sample sizes; n“5 per subgroup except in the 500 nmoles 
paraquat/hr + OPTC subgroup (n**4).
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Figure 20. Lung Glucose-6-phosphate Dehydrogenase Activity 
Data are expressed as pmoles NADP reduced/min./lung at 37° C + standard deviation. Groups coded with 
the sane letter were not significantly different (i.e., P > 0.05) by Two-way ANOVA and subsequent Duncan’s 
Multiple Range Test. The FLC group mean was compared to other group means by Student's t-test. There were no 
significant differences due to putrescine coadministration. Sample sizes: n“5 per subgroup except in the 500 
nmoles paraquat/hr + 0PTC subgroup (n°4).
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Figure 21. Lung Glutathione Reductase Activity 
Data are expressed as pmoles NADPH oxidized/rain./lung at 37° C + standard deviation. Groups coded with 
the same letter were not significantly different (i.e., P > 0.05) by Two-way ANOVA and subsequent Duncan's 
Multiple Range Test. The FLC group mean was compared to other group means by Student's t-test. There were no 
significant differences due to putrescine coadministration. Sample sizes: n*5 per subgroup except in the 500 
nmoles paraquat/hr + OPTC subgroup (n=4).
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Figure 22. Lung NADPH Content 
Data are expressed as nmoles NADPH/lung + standard deviation. Groups coded with the same letter were 
not significantly different (i.e., P > 0.05) by Two-way ANOVA and subsequent Duncan's Multiple Range Test. 
The FLC group mean was compared to other group means by Student* t-test. There were no significant 
differences due to putrescine coadministraion. Sample sizes: n=5 per subgroup except in the 500 nmoles 
paraquat/hour + 0PTC subgroup (n"4).
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Chapter 4 
Discussion
Paraquat Administration by osmotic pump 
Toxicologlcal studies of paraquat in animals have typically 
employed administration of a single toxic dose of the herbicide by 
various routes and have evaluated the resulting physiological and 
biochemical effects. Exceptions to this generalization include the 
experiments of Bus et al. (1975) that looked at effects on the GSH 
peroxidase enzyme system in rats exposed for three weeks to 100 ppm 
paraquat in their drinking water* and Dey et al. (1982) which examined 
the disposition of paraquat in rats after 19 days of exposure to 
paraquat administered subcutaneously via osmotic pump.
The resultB reported here demonstrate the effectiveness of 
continuous intravenous infusion of paraquat from Alzet osmotic pumps 
in rapidly achieving and maintaining for an extended period of time* a 
stable blood concentration of paraquat. Steady paraquat blood levels 
were achieved by the first sampling point of 18 hours demonstrating its 
short blood half life (20-30 minutes; Sharp et al.* 1972). Absorbed 
paraquat is excreted almost exclusively by the kidneys (Sharp et al., 
1972). Approximately 80% of the paraquat administered In this study was 
excreted In the urine* therefore as much as 20% of the total paraquat 
dose was unaccounted for and likely retained in the body. Similar 
results were achieved with putresclne coadministration but the blood and 
urine levels measured did not seem commensurate with the administered 
dose. The low blood levels of putrescine were indicative of a short
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blood half~ll£e for this polyamlne, resulting either from Its rapid 
degradation or a large volume of distribution.
The normal appearance and behavior of animals given the lower 
dosage of paraquat (250 nmoles/hr for seven days ■ LoPQ), coupled with a 
lack of observable lung histological changes, establish the usefulness 
of this experimental model In the evaluation of low-level, continuous 
exposure to paraquat. Manifestations of paraquat toxicity such as 
anorexia and hypoxia and the Involvement of toxicity to other organs 
such as the kidney, which could result In altered paraquat excretion did 
not occur. This type of exposure would lend Itself well to studies of 
the Initial biochemical leBlon(a) occurring In paraquat toxicity and/or 
the development of adaptive/reparative responses of the lung due to 
prolonged paraquat exposure. The rapid clearance of paraquat from the 
blood restricts fcn vivo studies of pulmonary accumulation of paraquat 
conducted with single doses (Det et al., 1982). Achievement of 
prolonged, steady-state blood levels of paraquat would facilitate 
kinetic studies of Its pulmonary accumulation, In vivo, and factors 
which may modulate this process.
Dose-dependency of lung paraquat content
The absence of any sign or symptom of intoxication In LoPQ rats and 
the normal appearance of their lungs upon histological evaluation, 
contrasted sharply with the rather characteristic pulmonary toxicity 
that developed In animals given 500 nmoles paraquat/hr (HIPQ). This 
reflected the dose-dependent differences between HIPQ and LoPQ groups in 
the lung paraquat content attained and, thus, demonstrated the direct 
relationship between lung paraquat content and the development of
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pulmonary toxicity. A total, cumulative paraquat does of 25.7 mg/kg and
51.4 mg/kg was administered to LoPQ and HIPQ animals, respectively, over
the infusion period. Zn both cases the total dose exceeded the
intravenous, single-dose LD^q (21 mg/kg; Sharp et al., 1972). The
contrasts in the rapid development of toxicity In rats given a single,
LD^q dose with the animals of this study, demonstrate the importance of
paraquat blood levels and the length of time those levels are maintained
in achieving toxic paraquat levels in the lung.
The greater paraquat concentration in the lungs, as compared to Che
blood with bath doses of paraquat, supported the occurrence of a
concentrative uptake process. The fact that the lung content of
paraquat was blood concentration-dependent, suggests that if the
pulmonary accumulation of paraquat did occur by the energy-requiring,
saturable uptake system described by Rose et al. (1974), paraquat
concentrations achieved at the site of pulmonary uptake were not
sufficient for the uptake system to operate at Its If the site of
paraquat uptake is, indeed, the alveolar epithelium, then the means by
which Intravascularly administered paraquat would become available to
this site would largely be by diffusion from blood through the vascular
endothelium (Rannels et al,, 1985). If dlffuslonal equilibrium was
achieved and the concentration of paraquat at the pulmonary uptake site
was equivalent to the blood concentration, those concentrations would
have been 1.34 pM (1.34 ± 0,05 nmoleB/ml blood) and 2.98 pM (2.98 ± 0.26
nmoles/ml blood) in rats given LoPQ and HIPQ, respectively. Both of
these concentrations would have been well below the 70 pH K determined* tu
by Smith et al. (1974) for paraquat uptake in their lung slice system.
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Lack of effect of putresclne coadminlatration 
on lung paraquat content 
Among the hypotheses addressed by this study was the ability of 
coadmlnlBtered putresclne to decrease accumulation of paraquat by the 
lung. While the results suggested the occurrence of concentrative 
pulmonary uptake of paraquat, there was no indication after seven days 
of exposure that coinfusion of putresclne, at the dosages employed, was 
able to effect significant reductions In lung paraquat content. This 
may have been due to a failure to achieve blood levels of putresclne 
sufficient to provide effective competition with paraquat at the uptake 
site. This is supported somewhat by the fact that only the B1FTC dose 
resulted In significant elevations of lung putresclne that could be 
attributed to putrescine administration alone.
Smith and Wyatt (1981) found that uptake of paraquat by lung slices 
from an Incubation medium was Inhibited approximately 50X by an 
equlmolar (10 pM) putrescine content. Therefore, it might seem that the 
blood putrescine levels found In this study (resulting from putresclne 
administration alone), which were at least double the blood paraquat 
concentration, should have been effective In inhibiting pulmonary 
paraquat accumulation. It Is, however, difficult to relate the data 
from the In vitro lung slice system to the intact animal model. In the 
lung slice, the site of uptake (alveolar epithelium) was directly 
exposed to the compounds in question, while in vivo, the compounds are 
separated from the site of uptake by the vascular endothelium and, 
therefore, have a barrier to cross before they can arrive at that site 
and be actively accumulated* Also, while the relative concentrations of
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putresclne and paraquat can be readily determined In blood* that 
relationship cannot be accurately measured at the uptake site and cannot 
be assumed to be the same as that found In blood. Therefore, It is not 
possible to compare the relative concentrations of putresclne and 
paraquat used In an in vitro incubation medium that result In inhibition 
of paraquat uptake vith that which may, or may not, have been achieved 
at the pulmonary uptake site, In vivo.
The only other experimental model available for useful comparison 
to the present study Is that of Rannels et al. (1985) which showed that 
In the Isolated rat lung perfused with a blood-free medium, a 50 (jM 
concentration of methylglyoxal bis (guanylhydrazone) (MGBG) added to the 
perfusate containing one uM paraquat effectively Inhibited pulmonary 
paraquat accumulation. The 50-fold excess of the nonmetabolizable 
polyamine analogue compared to perfusate paraquat content In the 
isolated lung study, far exceeded the blood putrescine/paraquat ratios 
attained In the present Investigation. This difference may explain the 
contesting results regarding Inhibition of pulmonary uptake of paraquat.
Since putresclne Is a metabolizable compound, It may be that 
greater blood levels of a nonmetabolizable putresclne/polyamine analogue 
such as HGBG could be achieved, In vivo than Is possible with 
putrescine. Because this compound was effective In Inhibition of 
pulmonary uptake of paraquat In the perfused lung (Bannels et al.,
1985), it*might also prove effective, in vivo, If adequate blood 
concentrations relative to paraquat can be safely maintained.
The absence of observable Inhibition of lung accumulation of 
paraquat in this study also contrasts with a similarly conducted
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investigation (Dunbar et al., 1965) that suggested in vivo inhibition of 
pulmonary paraquat uptake by coadministered putrescine might occur.
There was a major difference between the two studies which may have 
contributed to the discrepancy. In the previous study (Dunbar et al., 
1985) putresclne was administered subcutaneously, at a rate of 9317 
nmoles/hr (i.e. 1500 pg/hr). Here, putresclne was given I.V. rather 
than S.G. to avoid any variation in blood level due to absorption 
effects and metabolic degradation by extrapulmonary tissues (e.g. 
first-pass liver metabolism) before becoming available to the lung. The 
dose was also decreased from that given S.G. in anticipation of possible 
toxic effects resulting from such a large I.V. dose. Blood putrescine 
levels were not measured in the previous experiments and, therefore, 
comparisons of blood concentrations between these two studies cannot be 
made. But, the apparently lower lung paraquat levels observed in the 
previous study with putrescine coadministration suggests that the 
putresclne dosage rates employed previously may have resulted in higher 
blood putresclne levels than were reached in the present study, despite 
the difference in route of administration.
A lack of sufficient blood concentrations of putresclne to result 
in observable inhibition of paraquat accumulation could very well have 
been compounded by the fact that erythrocytes can accumulate putrescine, 
spermidine, and spermine (Moullnoux et al., 1984) and as much as 901 of 
blood polyamines can be transported in the red cell (Cohen et al,,
1976). Unfortunately, due to sample volume considerations, putresclne 
and polyamlne levels were determined in whole blood rather than plasma, 
therefore, actual plaBma levels of putresclne available for diffusion to
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the uptake site are not knovn. This was not a problem for paraquat 
since blood concentrations of this compound are equivalent to plasma 
levels (Sharp et al., 1972).
Effects of paraquat on tissue polyamlne metabolism
Blood concentrations of putresclne were more elevated In animals 
given Increasing doses of paraquat than they were, due to putresclne 
administration alone. The higher levels of blood putresclne In these 
rats might have been expected to be more effective In Inhibition of 
pulmonary paraquat uptake. However, these additional Increases in blood 
putresclne probably resulted as an adaptive or toxic response in the 
lung to already accumulated paraquat. Such elevations In the levels of 
polyamines In extracellular fluids (I.e., blood, plasma, and urine) are 
generally believed to reflect pathological conditions involving cellular 
proliferation and growth (Russel et al., 1983) (e.g. cancer, cystic 
fibrosis, psoriasis). The paraquat-induced Increases in blood 
putresclne observed in this study, likewise, probably reflect Increased 
putrescine production in paraquat-affected tissues. On the basis of 
this assumption, by far the largest contributor to blood putresclne (of 
the tissues analyzed) would have been the lungs, especially those of 
animals given HIPQ which demonstrated evidence of type II cell 
proliferation and exhibited a marked elevation of putrescine.
Paraquat-induced increase in lung spermidine suggested induction of 
subsequent steps of the polyamlne biosynthesis pathway, although 
activities of S-adenosylmethlonine decarboxylase (SAMDC) or spermidine 
synthetase were not directly measured. In contrast to putresclne, 
elevations In lung spermidine were not reflected sb an Increase in blood
66
spermidine. Blood spermidine was actually decreased In paraquat-exposed 
animals. The decreased blood spermidine found In the HIPQ group might 
be explained by poor nutritional status alnce a similar decrease w s b  
observed In the FLC group. A decrease In blood spermidine was also 
measured In the LoPQ group which would not have been explained by food 
limitation. It Is possible that LoPQ produced an effect on metabolism 
which caused a decrease In blood spermidine similar to that resulting 
from nutritional Impairment.
The marked elevations In lung putrescine, spermidine, and ODC 
activity resulting from exposure to HIPQ for seven days were similar to 
those observed by Hacker et al. (1983) in lungs of rats exposed to 85% 
oxygen (classically, a tolerance-producing concentration) for up to 
seven days, followed by subsequent exposure to 100Z oxygen for up to 10 
days. The data are also consistent with the findings of Thet et al. 
(1984) who found elevations In ODC activity, putrescine, spermidine, and 
spermine In rat lungs recovering from oxygen-induced Injury. The 
comparable effects of paraquat and hyperoxla on lung ODC and polyamines 
demonstrate yet another similarity in the lung's biochemical response to 
paraquat exposure and hyperoxla. They are not necessarily Indicative of 
the possible similarity in toxic mechanism of paraquat and oxygen, but 
could rather be a generalized response to tissue Injury resulting in, or 
associated with, cellular proliferation and growth.
Cellular proliferation in the lung was observed in both this study 
and that of Thet et al. (1983). Cellular proliferation and stimulation 
of polyamlne synthesis were shown to be closely related occurrences when 
Thet et al. (1983) demonstrated that the proliferative process could be
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attenuated by an inhibitor of ODC, difluoromethylomlthlne (DFMO), 
resulting in overall Inhibition of the polyamlne biosynthetic pathway. 
This suggested a modulating role for polyamines In repair of lung 
subsequent to oxygen damage. Similarly, the Increases in lung 
polyamines and ODC In HIPQ rats may reflect stimulation of repair 
mechanisms. The changes In polyamlne metabolism might also have played 
a role In the adaptive Induction of lung GSH, G6PD, and GR via Its 
regulatory role in RNA and protein synthesis (Bachrach, 1973). It is 
also possible that increased lung putrescine directly enhanced activity 
of G6PD as demonstrated by Dodds (1986), in vitro.
While proliferation of endothelial and epithelial cells may be 
Important in the repair of lung Injury, excessive proliferation of 
interstitial cells can have severe deleterious effects (Hacker et al. 
1983). In the case of paraquat intoxication this may be expressed as the 
characteristic, typically lethal, pulmonary fibrosis. Hacker et al. 
(1983) proposed that antimetabolites of polyamlne synthesis may be 
useful for suppression of excessive cellular proliferation after lung 
Injury which may otherwise result In interstitial pneumonitis or 
fibrosis. Similarly, the fact that lungs of rats exposed to HIPQ 
exhibited large Increases In putresclne and spermidine associated with 
their observed state of cellular proliferation and beginning collagen 
deposition, suggests that such an intervention may be useful in 
combating the specific problem of paraquat-induced pulmonary fibrosis.
Except for an apparent effect of HIPQ on heart polyamines, the lack 
of effect of paraquat on the polyamlne profile of any other organs 
analyzed would appear to be further demonstration of the known
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selectivity of paraquat toxicity for the lung. From the data It would 
appear that this selectivity Is, In large measure, a reflection of the 
retention of relatively high levels of paraquat within the lung. 
Additionally, since significant changes In ODC and lung polyamines 
occurred only In the HIPQ animals. It suggests that those alterations 
resulted more as a response to cell damage than a direct response to 
paraquat exposure.
Generalizations concerning the diagnostic value of tissue polyamlne 
profiles have been made (Russell, 1983). Elevations In ODC and 
putresclne occur In tissues which have been stimulated to Initiate cell 
proliferation. Increased spermidine levels are associated with the next 
step In the proliferative process, that Is, increased RNA content and 
actual cell replication. Elevations In tissue spermine are related to 
the process of differentiation. On the basis of these generalizations, 
the polyamlne profile of the HIPQ lungs Indicates that these lungs were 
in the process of cellular proliferation which Is consistent with their 
hlstopathology.
The Increase in heart putresclne concentration resulting from HiPQ 
Infusion was very Interesting In that It may not have been a direct 
effect of paraquat on the heart. Itself. Russell et al. (1971) reported 
that experimental constriction of the pulmonary artery of rabbits to 
32-42Z of original diameter resulted In growth of the right ventricle, 
which was preceded and accompanied by Increases in ODC and SAMDC 
activity and putrescine, spermidine, and spermine levels. The 
appearance of the lungs of animals given HiPQ suggests that the animals 
could have experienced pulmonary hypertension, thus, putting stress on
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the right ventricle o£ the heart. The increased levels of putresclne in 
the heart of these animals may* therefore, reflect the early stages 
(i.e., prior to actual growth since no differences in heart weights were 
noted) of stress-induced cardiac hypertrophy.
Heart putrescine content was also increased in all animals 
administered putrescine. Although these increases were small and could 
have resulted from blood contamination of the tissue preps they did 
prove to be statistically significant due to the normally low levels of 
putresclne found in the heart.
While the decrease in heart spermine (and hence increased 
spermidine/spermine ratios) observed in these animals resembles the 
occurrences in regenerating rat liver (Ralna et al., 1966) It contrasts 
with the increased spermine levels accompanying stress-induced cardiac 
hypertrophy (Russell et al., 1971). The discrepancy between these two 
results may be due to differences in etiology of the two stresses (i.e., 
mechanical constriction of the pulmonary artery versus pulmonary 
obstruction as a result of chemical intoxication) or a species 
difference. Additionally, the fact that lung spermine was also 
decreased in the LoPQ animals in the apparent absence of any myocardial 
stress suggests that paraquat had some effect on this polyamlne in the 
heart that was not completely attributable to pulmonary hypertension 
resulting from lung damage. Perhaps, for example, the activity of 
cardiac spermine synthetase might be especially sensitive to destruction 
by paraquat-generated free radicals.
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Effects on lung glutathione and glutathione peroxidase system enzymes 
The results of Investigations of ozone's pulmonary toxicity led 
Chow and Tappel (1972) to propose that activities of GSH peroxidase 
system enzymes (GSH peroxidase, GR, and G6PD) are increased In response 
to oxidant stress. Likewise, Kimball et al. (1976) found Increased 
lung levels of GSH and total nonprotein sulfhydryl and increased 
activity of GSH peroxidase, GR, and G6PD In rats exposed to 90% and 85% 
oxygen for seven and 14 days. As is the case for prolonged ozone and 
oxygen exposure, the Increase of pulmonary G6PD, GR, and GSH levels 
reported here may have occurred, In part, In response to superoxide 
radical-mediated toxic reactions of paraquat (reviewed by Bus and 
Gibson, 1984). Similar increases of lung G6PD and GR activities were 
reported by Bus et al. (1976) in rats exposed to 100 ppm paraquat In 
drinking water for three weeks. The fact that the activity of GSH 
peroxidase was not increased In either the present study or that of Bus 
et al. (1976) however, contrasts with the Increased activity of this 
enzyme observed In experiments involving exposure to ozone (Chow and 
Tappel, 1972), oxygen (Bus et al., 1976); (Kimball et al., 1976); Cross 
and Last, 1977); (Ospltal et al., 1983), or 48 hours after a single 
toxic dose of paraquat (Reddy et al., 1977). The lack of a 
paraquat-induced increase In lung GSH peroxidase activity while 
activities of the other enzymes attributed to the GSH peroxidase system 
are increased cannot be conclusively explained. It is possible that the 
dosage rates of paraquat employed in this Investigation did not result 
in production of HjOj and/or lipid hyperoxides at rates high enough to 
stimulate Induction of GSH peroxidase.
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Generally, activity of G6PD and turnover of the pentose phosphate 
pathway, are increased In response to Increased cellular demand for 
NADPH. Along with generation of oxygen-free radicals, NADPU depletion Is 
the major biochemical event, stemming from the "redox cycling" of 
paraquat In lung cells. In this experiment an Increased demand for 
NADPH could have resulted from Increased consumption of NADPH in the 
enzymatic reduction of paraquat, in GR-catalyzed reduction of GSSG, and 
an Increase in turnover of reductive biosynthetic pathways requiring 
NADPH (e.g. lipid biosynthesis). Additionally, an Increased turnover of 
the pentose phosphate pathway would be expected to provide more 
rlbose-S-phosphate as substrate for nucleic acid synthesis and repair* 
The ability to maintain NADPH-dependent biosynthetic pathways and 
supplies of nucleic acid precursors would be vitally important in 
reparative/adaptive processes of the lung.
Oxidized glutathione has also been demonstrated to have a 
regulatory role in the activity of G6PD (Eggleston and Krebs, 1974) 
which is mediated by a thiol transferase-catalyzed formation of mixed 
disulfides between the enzyme and GSSG (Watanabe et al,, 1972; Isaacs 
and Binkley, 1977a and 1977b). In this regard, Keeling et al. (1982a 
and 1982b) reported Increased levels of lung-mixed disulfides as a 
result of exposure of rats to paraquat and postulated that excess GSSG 
produced as a result of paraquat-generated oxidant stress would react 
with protein sulfhydryls to form glutathlone-protein disulfides. This 
would explain their findings of increased levels of mixed disulfides 
while GSSG levels remained constant. Formation of similar mixed 
disulfides between glutathione and G6PD could result in Increased
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activity of the enzyme (Hstanabe et al., 1972; Isaacs and Binkley, 1977a 
and 1977b) and hence explain their observed increase in turnover of lung 
pentose phosphate pathway.
Results similar to those of Reeling et al, (1982b) are reported 
here. Despite the presumed oxidant stress Imparted by paraquat, there 
was no observable change in lung levels of GSSG at either doBage 
employed. Although levels of glutathlone-proteln mixed disulfides were 
not measured in this study, an increase in their production may have, as 
in the studies of Keeling et al. (1982b), explained the lack of a net 
increase in lung GSSG levels. If an increase in these mixed disulfides 
did occur, they likely contributed to the paraquat-induced Increases in 
lung G6PD and GR.
Besides mixed disulfides serving as a "hidden" form of GSSG, 
another factor which may have contributed to the lack of accumulated 
lung GSSG was that the rate of GSSG production may never have exceeded 
the paraquat-enhanced capacity of GR to reduce it back to GSH. Also, 
limiting the cellular accumulation of GSSG is its leakage out of the 
cell. Such efflux of GSSG has been demonstrated in isolated, 
paraquat-perfused rabbit-lungs (Dunbar et al., 1984) and may occur In 
vivo, as well.
Polyamines may be effective antioxidants as a result of their 
ability to scavenge superoxide anion (Vanella et al., 1979). Khanna et 
al. (1982) demonstrated an apparent protective effect of putrescine and 
polyamineB administered prior to a single dose of paraquat. They showed 
that putreaclne inhibited the stimulation of lipid peroxidation by 
paraquat and attenuated the subsequent increase in superoxide dlsmutase
activity In the lung. They attributed their findings primarily to the 
proposed free radical scavenging ability of the polyamines. Putresclne 
haB also been demonstrated to stimulate activity of G6PD In vitro (Dodds 
et al., 1986). In thie study, however, exogenously administered 
putrescine was not able to alter the paraquat-induced changes In the 
measured lung biochemical parameters either through attenuation of 
oxidant stress, direct modulation of enzyme activities, or Inhibition of 
paraquat accumulation.
The biochemical responses of the lungs to paraquat exposure that 
occurred In this Investigation could have resulted from 
reparative/adaptive proliferation of certain cell populations with 
normally high metabolic capacities and/or normally higher levels of 
these particular biochemical systems. For example, type II epithelium 
and non-clliated bronclolar epithelium (dara cells) are endowed with 
higher metabolic capacity than differentiated type I cells and airway 
lining cells. Alternatively or concomitantly, the increases In GSH, 
G6PD, GR, and polyamines could have occurred at the molecular level 
through stimulation of new synthesis of these molecules. Many of the 
biochemical changes observed in the HiPQ animals may have resulted from 
lung damage with subsequent proliferation of type II cellB. Since no 
such shift in cell populations was observed in lungs of LoPQ animals, 
the measured Increases in GSH, polyamines, and measured enzyme 
activities in the lungs of rats In these groups were probably the result 
of increased GSH and enzyme synthesis or enzyme activation by existing 
cells. It is not known whether or not this occurred in direct response 
to paraquat-generated oxidants and increased oxidation of NADPH or as a
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result of Initiation of reparative processes In response to sublethal 
cell damage.
By whatever mechanlam(s) paraquat-induced Increases In lung 
biochemical parameters occurred) these changes Imply that the lungs had 
an Increased capacity for defense against paraquat toxicity mediated by 
paraquat-generated oxygen free radicals by virtue of Increased lung GSH 
and higher activities of G6PD and GR.
The pulmonary damage observed In the rats given H1PQ, however) 
suggests that enhancement of lung GSH, G6PD, and GR was, in fact, of 
little benefit in prevention of the manifestation of paraquat's lung 
toxicity. There are several possibilities which may explain the 
apparent Inability of this stimulated lung antloxldant system to protect 
against paraquat damage. First, it is possible that at the higher 
paraquat infusion rate, and therefore, higher lung paraquat levels, 
paraquat-induced production of oxygen-free radicals exceeded the 
antloxldant capacity of GSH system. Although the rats given LoPQ 
exhibited no observable damage (at the level of light microscopy). It is 
possible that if the infusion of paraquat at the lower rate had 
continued, the lung paraquat content would likewise have reached levels 
which could have overwhelmed this antioxidant mechanism, resulting In 
lung damage. Second, it is also possible that an Increase in components 
of the GSH peroxidase system serveB no real functional advantage in 
adaptation to oxidant stress, especially in the absence of Increased 
activity of GSH peroxidase itself. The Importance of Increased activity 
of GSH peroxidase system enzymes in the development of Increased 
tolerance to oxygen toxicity has recently been called to question by
Ospital et al. (1983). They found that increases In activities of G6PD, 
GR, GSH peroxidase, and nonprotein sulfhydryls In rat lungs after 
exposure to 85Z oxygen did not correlate with the resulting tolerance to 
subsequent challenge with 100% oxygen. This, they pointed out, would 
not preclude the Importance of this system In protection of tissues from 
normally present levels of oxidants, ffhlle It Is true that rats In this 
Investigation given LoPQ did not exhibit signs of lung damage it Is not 
possible to determine from these data whether this absence of damage was 
related to any protective effect imparted by Increased lung G6PD, GR, 
and GSH. This question might be resolved by coadmlnlBtratlon of 
buthionlne sulfoxlmlne to inhibit GSH synthesis and/or 
l»3-Bis(2-chloroethyl)-l-nltrosourea (BCNU) to inhibit the activity of 
GR and determination of whether these interventions result In lung 
damage from an equivalent dose of paraquat.
A third explanation of the apparent inability of Increased activity 
of this antloxldant system to protect from manifestations of 
paraquat-induced lung damage could be that this is not the primary 
antloxldant mechanism employed in the defense against paraquat-generated 
free radicals. Indeed, Kombrust and Mavis (1979) proposed that vitamin 
E was the major cellular antioxidant protecting against peroxidative 
membrane damage, olnce they were able to correlate resistance to in 
vitro peroxidation of mlcrosomes from various tissues to vitamin E 
content. Bus tst al. (1976) demonstrated that acute paraquat treatment 
resulted In decreased lipid soluble antioxidants (e.g. vitamin E) In 
mouse lung but had no effect on lung GSH content. This might suggest 
that In lung vitamin E may play a more significant role in
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detoxification of paraquat-generated oxygen radicals. However, these 
experiments contrast with the present Investigation In that Bus et al. 
(1976) used mice and acute paraquat exposure and are, therefore 
difficult to equate with the results obtained from rats given long-term 
paraquat infusion.
Lastly, the apparent lack of protection of the lungs from paraquat 
damage by increased G6PD, GR, and GSH suggests that the primary 
mechanism of lung paraquat toxicity Involves more than lipid 
peroxidation and other free radical-mediated reactions. For example, 
the ability of paraquat to stimulate consumption of NADPH described 
above was readily apparent In Che lungs of H1PQ animals. Similar losses 
of rat pulmonary NADPH occurring as a result of paraquat exposure have 
been demonstrated by Hitachi et al. (1977) and Keeling and Smith 
(1982b). Depletion of lung NADPH Is often proposed as one of the 
primary mechanisms of paraquat toxicity (Boyd, 1982). In light of this, 
it is Interesting that depletion of lung NADPH was demonstrated only in 
rats given H1PQ and that those were the only animals exhibiting 
morphological evidence of paraquat-induced lung damage. This apparent 
relationship between NADPH loss and lung cell damage was also observed 
by Keeling and Smith (1982b) in rats following subcutaneous, single-dose 
paraquat. Despite the similar observed relationship between lung cell 
damage and loss of NADPH in this study, the data do not support a 
cleorcut cause-effect relationship. That Is, did NADPH depletion result 
in cell damage or was NADPH depletion the result of the death or 
metabolic Impairment of cells?
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Additional demand on NADPH-producing aystens might have been 
incurred In the lungs of the H1PQ rats due to their poor nutritional 
status. It was apparent from the FLC group that limitation of food 
consumption could result in a similar decrease in lung NADPH. The loss 
of NADPH In this latter group# however# was associated with a 
significant decrease In lung G6PD activity while the decreased NADPH in 
the H1PQ group occurred even though these animals exhibited the most 
marked Increase in lung G6PD. This might# therefore# reflect a 
decreased availability of glucose-6-phosphate for passage through the 
pentose phosphate pathway due to impaired nutrition.
Even though lipid. peroxidation may not be the primary mechanism of 
paraquat toxicity# the loss of NADPH In the lungs of animals given HiPQ 
coupled with the possible insufficient elevation of lung GSH (although 
It was elevated over the levels of the Food-limited Controls) could 
possibly have contributed to subsequent peroxidation of membrane lipids 
which could then have been a factor in paraquat toxicity. Indeed, it 
has been demonstrated that lipid peroxidation does not occur, in vivo# 
until GSH and NADPH are depleted (Yaunes and Siegers, 1981).
CHAPTER 5 
Conclusions
Continuous, intravenous infusion of paraquat from a surgically 
implanted osmotic pump appears to be an effective method for study of 
long-term effects of this herbicide. It has an advantage over other 
routes of administration in that it avoids variable absorption effects 
and eliminates the peaks and valleys in blood concentration vhich occur 
with singlet repeated Intravenous doses. Thus, rapid attainment of a 
steady-state blood level of the compound can be achieved. Paraquat 
administration rates and durations can be selected, as the seven-day 
LoFQ employed in this investigation exemplifies, vhich will not result 
in overt pulmonary toxicity or Involve other organs. It is then possible 
to study the more Bubtle biochemical and morphological alterations which 
are a direct response to paraquat. These changes may be indicative of 
an early adaptive response and/or the first, critical steps in a more 
slowly developing pulmonary toxicity.
This experimental model should also prove useful in studies of the 
mechanism of pulmonary paraquat accumulation and interventions 
potentially useful in limiting this process. Despite the ability of 
putresclne and MGBG to Inhibit uptake of paraquat into lung slices and 
the perfused lung, respectively, continuous intravenous coadministration 
of putresclne at dosage rates up to 20 times that of paraquat did not 
result in a decrease in terminal (Beven day) lung paraquat content in 
thlB study. The lack of inhibition of pulmonary paraquat uptake 
reported here may have resulted from maintenance of insufficient 
putresclne at the uptake site relative to paraquat concentration.
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The Increases In activities of lung G6PD, GR, and TLG are 
consistent with the proposed similarity of paraquat toxicity to that of 
oxygen. They are probably attributable to paraquat's ability to produce 
superoxide anion as a result of "redox cycling" between parent compound 
and a paraquat free radical. Despite the presumed importance of GSH and 
activities of enzymes of the GSH peroxidase system In protection front 
oxidant stress, the lungs of H1PQ animals exhibited lung damage typical 
of paraquat. This, plus the apparent inability of the lungs to Increase 
activity of GSH-peroxldase itself, seems to contradict the importance of 
GSH and GSH peroxidase system enzymes in protecting against 
paraquat-induced oxidant stress and the relative Importance of 
paraquat-generated oxidants in development of pulmonary toxicity. The 
fact that HADPH is decreased significantly only in the damaged lungs of 
the H1PQ group may be supportive of a primary role of NADPH depletion in 
development of the pulmonary toxicity of paraquat.
The paraquat-induced alterations in lung polyamine content and 
activity of ODC (in HiPQ rats) are, likewise, similar to those reported 
to occur as a result of exposure to hyperoxla and in recovery from 
oxygen-induced lung damage. Since changes in ODC activity and lung 
polyamines occurred only in the HIPQ animals, it suggests that these 
alterations resulted as a non-specific response to paraquat-induced lung 
damage. The changes in lung polyamines may represent a reparative 
response to this damage which, if excessive, may contribute to 
subsequent flbrotic changes. This Is believed to be the first report of 
such paraquat-Induced effects on the lung polyamlne system in vivo.
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APPENDICES
A. Liver and Kidney Polyamine Profile*
Paraquat Dosage Rate (nmoles/hr)
Organ Polyamine 0 250 500 FLC
Putrescine 74 ± 40 64 ± 30 70 ± 35 37 ± 11
(15) (15) (14) (5)
Liver Spermidine 293 ± 59 351 + 76 318 ± 76 234 ± 30 a
(15) (15) (14) (5)
Spermine 412 ± 83 367 ± 55 350 ± 76 295 ± 74
(15) (15) (14) (5)
Putrescine 47 ± 23 48 ± 20 90 ± 46 21 ± 5
(15) (15) (14) (5)
Kidney Spermidine 294 ± 54 301 ± 64 275 ± 73 183 ± 31a
(15) (15) (14) (5)
Spermine 422 ± 98 372 ± 92 331 ± 110 219 ± 53
(15) (15) (14) (5)
*Data are expressed as nmoles polyamine/gm tissue ± standard deviation. Two-way ANOVA revealed no 
significant differences in liver or kidney polyamines resulting from any main treatment. Numbers in 
parentheses indicate sample size.
aStudent's t-test indicated that both liver and kidney spermidine was significantly decreased 
(P < 0.05) in the FLC group compared to all other groups.
B. Activities of Lung 6-phoshogluconate Dehydrogenase and Glutathione Peroxidase*
Paraquat Dosage Rate (nmoles/hr)
Enzyme 0 250 500 FLC
6-phosphogluconate dehydrogenase 3.24 ± 1.28 
(15)
4.35 ± 0.41 
(15)
4.58 ± 2.28 
(14)
2.68 ± 0.09 
(5)
Glutathione Peroxidase 6.15 ± 0.85 
(15)
5.93 ± 1.18 
(15)
5.83 ± 1,44 
(14)
5.59 ± 0.44 
(5)
*Data are expressed as umoles HASP reduced/min./lung or NADPH oxidized/min./lung ± standard 
deviation for 6-PGD and GSH peroxidase, respectively. Measurements were made at 37s C. Two-way ANOVA 
revealed no significant differences due to any main treatment. Numbers in parentheses indicate sample 
size.
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